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Chapter 1: Thesis Overview 
 
This chapter aims to provide an overview of the dissertation presented here as a whole. It 
outlines the purpose, content and organisation of the following literature review (chapter 2) and 
empirical paper (chapter 3). This chapter also intends to show how the two main chapters fit together, 
and how they represent important research within the wider literature. 
Fibromyalgia (FM) is a chronic pain syndrome characterised by pain in the soft tissues of the 
body, general fatigue and sleep disturbance (Wolfe et al., 1990). Many individuals face a long and 
difficult journey to receive a diagnosis of FM. A recent survey reported that on average, respondents 
waited 2.3 years and saw 3.7 physicians before receiving a diagnosis of FM (Choy et al., 2010). 
Furthermore, individuals with FM have also reported that there is a considerable stigma associated 
with having the condition. In one qualitative study, women with FM reported feeling that others, 
including their physicians, questioned their credibility when reporting symptoms and their work ethic; 
and also implied that their illness was entirely psychological. As a result, the women reported that 
they coped with these difficulties either by withdrawing from social activity to avoid such 
experiences, or by putting on a façade that masked the true extent of their suffering (Asbring & 
Narvanen, 2002). 
Current medical and psychological treatments for FM are limited in success with regards to 
providing consistent benefits to the FM population as a whole (Abeles, Solitar, Pillinger & Abeles, 
2008; Vlaeyen & Morley, 2005). Traditionally the dominant approach to intervention within both the 
medical and psychological fields is to focus on the reduction of negative symptoms. In contrast, the 
growing field of positive psychology continues to demonstrate the utility of exploring the processes 
and conditions that are conducive to optimal human functioning (Seligman & Csikszentmihalyi, 2000) 
as an alternative or complimentary approach to conventional methods of healthcare. Subjective well-
being (SWB) can be defined as “a person’s cognitive and affective evaluations of his or her life” 
(Diener, Lucas & Oishi, 2002, p.63). A large body of evidence suggests that individuals who have 
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higher SWB enjoy a range of positive outcomes, including health-related benefits (e.g. Deiner & 
Chan, 2011). 
The application of a positive psychology approach may be particularly relevant to FM, where 
there is growing evidence of a specific deficit in positive affect (PA), a major component of SWB. 
Chapter 2 of this thesis is a systematic review of the literature regarding PA in individuals with FM. It 
focuses on the quantitative literature and specifically aims to answer the question: is there a deficit in 
PA in individuals with Fibromyalgia relative to other pain conditions, general health conditions, and 
also the general population? 
The literature review begins by giving a rationale as to why exploring the evidence for a 
deficit in PA specific to the FM population is important. It also summarises the background literature 
regarding the structure of affect, as well as theories relating to the potential function, and proposed 
mechanism of action, of PA. Next, the method section outlines the systematic methods that were used 
to identify the relevant studies that are included in the review. This is followed by the results section, 
which succinctly presents a synthesis of the characteristics of the included studies, along with the key 
findings regarding PA. The discussion section considers how the findings answer the question of 
whether there is a specific deficit in PA within the FM population. It also considers the clinical 
implications of the findings. This is followed by an in-depth discussion of the potential limitations of 
the review, in terms of both the quality of the studies included and also the methodological 
considerations of the review process itself. Finally, recommendations for future research are made. 
It has been hypothesised that hope is a major contributor to well-being (Snyder, 2002). In 
non-clinical samples, the association between hope, particularly goal-focused hope, and SWB has 
been well documented (e.g. Snyder, 2002). More recently, mindfulness has also been identified as 
promoting increased SWB (e.g. Brown & Ryan, 2003). Chapter three of this thesis is an empirical 
paper that aims to add to the current literature by exploring the specific impact SWB has on 
improving FM-related symptoms and difficulties. It also builds on the existing literature in non-
clinical samples by investigating if goal-focused hope and mindfulness significantly contribute to the 
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promotion of SWB within the FM population. To achieve these aims, the research utilises structural 
equation modelling (SEM) techniques to simultaneously explore the relationships amongst the key 
study variables. This was done by pre-specifying a hypothesised model of how hope and mindfulness 
may lead to increased SWB in FM, based on past research. The extent to which this model fit the 
actual data collected was then examined. 
The empirical paper starts by considering the importance of SWB with regards to physical 
health outcomes. It also introduces the concepts of goal-focused hope and mindfulness, and begins to 
consider the theory behind how they may lead to higher SWB within the FM population. The method 
section then gives details of the study’s participants, measures and procedures. It also reports how the 
data was analysed, with a particular focus on a description of SEM. Next, the results section begins 
with details of how the data was prepared and includes findings from the preliminary analysis. The 
main focus of this section involves testing the hypothesised SEM model against the study data. 
Finally, the discussion section reflects on the study’s findings within the context of existing research 
and theory. Potential limitations of the study are considered, as well as the implications for future 
research and clinical practice. This section is concluded with a succinct summary of the study’s key 
contributions to the literature and how this should inform future work. 
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2.1 Abstract 
 
Individuals with fibromyalgia suffer from a range of symptoms that prove difficult to treat using 
traditional medical approaches. Recent research has focused on the role that positive affect (PA) may 
play in the maintenance of fibromyalgia symptoms. This review aimed to appraise the evidence of a 
specific PA deficit in individuals with fibromyalgia. Online databases were searched systematically to 
find relevant literature. All included studies were assessed for quality. Twelve studies were identified, 
totalling 1,075 participants with fibromyalgia. The primary outcome of interest was PA, and the effect 
sizes of group differences were calculated.  Eleven of the 12 studies found that individuals with 
fibromyalgia reported significantly lower levels of PA when compared to a range of other study 
populations including individuals with osteoarthritis, rheumatoid arthritis, mixed health conditions, as 
well as healthy controls. Effect sizes ranged from 0.45 to 1.08, with the majority of effect sizes being 
medium-to-large. These represent promising findings; however the quality of the studies was affected 
by poor definition of fibromyalgia and comparison groups, lack of power analyses, failure to 
adequately control for group differences, and concerns that some of the different study samples may 
include the same participants. Future research should initially aim to clarify the presence of a specific 
PA deficit in fibromyalgia through well-controlled, high quality studies. Subsequent research should 
further explore the underlying mechanisms through which PA affects symptomology in fibromyalgia, 
as well as the design and evaluation of clinical interventions aimed at improving well-being through 
cultivating PA. 
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2.2 Introduction 
 
Fibromyalgia (FM) is a chronic pain syndrome characterised by pain in the soft tissues of the 
body, general fatigue and sleep disturbance. Prevalence studies suggest that between 2% and 6% of 
the general population suffer from FM, and that it is far more common in women than in men [3,46]. 
The pathology of FM remains unknown. Indeed, the diagnostic criteria for FM is widespread pain, 
occurring for at least three months in the absence of any other explanatory physical cause [72]. 
Perhaps as a result of this etiological ‘mystery’ there is currently an absence of any one drug treatment 
that is reliably beneficial to the FM population as a whole [1].   
FM is also marked out from other chronic pain conditions by the high levels of psychological 
distress frequently reported by those with the condition. Research has consistently indicated that 
individuals with FM are more likely to report increased levels of psychiatric disorders such as anxiety 
and depression compared to the general population, and other comparable pain conditions 
[25,50,58,59]. Not surprisingly then, a number of studies have investigated the efficacy of 
psychological interventions for FM and the wider chronic pain population. Although research that 
directly compares the efficacy of pharmacological and psychological interventions is lacking, results 
from meta-analyses and other reviews have found comparable outcomes [57]. The British Pain 
Society recommends chronic pain treatment should be multimodal and include a substantial cognitive-
behavioural approach [7]. However, as with drug treatments, no single psychological treatment 
appears to offer consistent benefits to the entire chronic pain population [62]. A more recent 
development, is the concept of matching service users to particular treatment options based on their 
baseline characteristics that may influence treatment outcomes [51,62].  
It is clear then, that there is much room for improvement in the current understanding of the 
specific factors that underlie and influence the high levels of pain, disability and distress in FM. 
Furthermore, improved knowledge of the specific characteristics of individuals with FM which 
differentiate them from the wider chronic pain population may be useful to match them to the most 
appropriate interventions. 
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Although research into the psychological aspects of FM has traditionally focused on relieving 
negative affective symptoms such as depression, over the last two decades, a number of studies have 
begun to examine the unique role positive affect may play in FM compared to other pain conditions. 
Positive affect (PA) in this context refers to the extent to which someone experiences positive mood 
states such as joy, confidence and alertness [65]. In contrast, negative affect (NA) reflects the degree 
to which an individual experiences states such as anger, guilt and fear.  
There is debate in the literature as to how affect is best understood. One approach is that 
affect is best conceptualised as a single bipolar dimension with PA at one end and NA at the other 
[26,52]. The implication being that at any one time an individual can be experiencing PA or NA, but 
not both. There is, however, substantial evidence that would suggest that this single continuum theory 
does not adequately explain the experience of PA and NA. Watson and Tellegen [70] proposed a 
highly influential hierarchical model of affect. According to this theory, lower order specific 
emotional states (e.g. fear, joy) map onto the two broad high order orthogonal factors of PA and NA, 
which reflects the overall valence of whether they are negative or positive states. This model states 
that PA and NA vary largely independently from each other. It is possible, for example, that an 
individual may experience both high levels of PA (e.g. feeling enthusiastic) and high levels of NA 
(e.g. feeling nervous) at the same time. There is a considerable body of findings that supports an 
independent affect factor structure [41,64,66,69]. What is more, when defending their model, 
Tellegen and colleagues [55] note that PA and NA have differential effects on information processing 
[40], are associated with different personality traits [9,36,42,67], and have also been linked to 
different neuropsychological and behavioural activation systems [10,56].    
 
Benefits of Positive Affect 
There is evidence that ‘happy’ people enjoy a range of better physical health outcomes, 
compared to their less happy counterparts. Firstly, there is compelling research that suggests 
happiness predicts longevity, in that happier people live for longer [16]. Secondly, longitudinal data 
indicates that PA is also negatively associated with morbidity, the likelihood of an individual 
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developing health conditions. Diener [15] reports that long-term studies have shown that individuals 
who experienced more positive emotions are less likely to experience a range of health conditions 
later in life, including cardiovascular disease, mental health difficulties and alcohol-related liver 
disease. Lastly, low levels of well-being have been linked with depression [34], which in turn has 
been consistently associated with poorer outcomes in physical illnesses [43].  
For the FM population specifically, there is growing evidence that PA is linked to a range of 
outcomes. Higher levels of PA have been associated with reduced levels of pain [48,77] as well as 
increased pain tolerance [21,61], lower levels of negative affectivity [75], increased physical 
functioning [61] and a reduced risk of psychiatric co-morbidity [28]. 
 
Theoretical Mechanisms of Positive Affect 
One of the prevailing ideas regarding the value of PA conceptualises it as a psychological 
resource to be drawn upon during difficult times. This is exemplified by Fredrickson’s broaden-and-
build hypothesis [24]. From an evolutionary perspective,  negative mood states typically occur in 
situations that are threatening in some way, and that require immediate action to stay safe; for 
example being confronted by an assailant would produce a fear response triggering ‘fight or flight’ 
behaviour [45]. In such circumstances, a narrowed thought-action process is beneficial as it promotes 
speed of response, and thus increases survival odds. Fredrickson’s model argues that in contrast to 
this, PA typically occurs in non-threatening situations where immediate action is not necessary. As 
such, positive emotions have the opposite effect to negative ones: they broaden an individual’s 
“thought-action repertoire” [45] c expanding the range of thoughts and actions that come to mind. For 
example, research has demonstrated that the thinking styles of individuals experiencing high levels of 
PA are more creative, integrative, flexible, efficient and open to new information [20,30-33]. 
Therefore, those individuals who consistently have higher levels of PA, will cope better during times 
of stress, such as pain flare ups, as they will have built up a larger wealth of resources to draw from.  
More recently, Zautra and colleagues [73,78] have developed the Dynamic Affect model, 
specifically with the chronic pain population in mind (though applicable to the general population). 
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Drawing from the aforementioned existing models and theories about the construct and functions of 
PA and NA, the model accounts for supposed differences in the way PA and NA relate to each other 
both between and within individuals over time. The Dynamic Affect model proposes that during calm, 
stress free times, PA and NA work largely independently of each other. At times of low-threat it is 
beneficial to process both positively- and negatively-valenced information as it allows an individual to 
access and process the widest range of information available, thus resulting in the most optimal 
response. However, in line with the evolutionary perspective of NA, at times of increased stress, rapid 
information processing is preferable, thus an individual’s attention is narrowed to immediate threats in 
order to produce quick action to neutralise the threat. The Dynamic Affect model specifies that at such 
times, negative information is preferentially attended to over positive information, and thus NA and 
PA “fuse” together into a single bipolar continuum becoming highly inversely related. As the authors 
propose the purpose of this fusing is to narrow attention to immediate threats, it could be inferred that 
fusing represents a specific reduction in the processing of positively-valenced information, which may 
lead to a decrease in PA. What it does not necessarily imply is an increase in the amount of 
negatively-valenced information leading to increased NA.  
The model proposes that everyone will demonstrate within-person changes in affectual 
processing between times of low and high stress to some extent. However, it also predicts between-
person differences such that certain individuals, for example those with chronic pain, are likely to 
experience the fusing of PA and NA to a greater extent. The authors suggest that for those suffering 
from chronic pain, the experience of pain is likely to be a frequent stressor. Whilst the Dynamic 
Affect model is clearly complimentary to the Broaden-and-Build hypothesis in several ways, there are 
key differences in the predictions it makes regarding how higher PA may help an individual to cope 
better at times of stress. Specifically, the model would imply that those who are able to maintain 
higher levels of PA during times of stress, such as pain flare ups, will cope better than those with low 
PA. 
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Potential Predictors of Positive Affect in Fibromyalgia  
A range of psychosocial factors have been identified as potentially influencing PA within the 
FM population. Unsurprisingly, times of increased pain has been associated with experiencing lower 
PA [35,49,76,77]. As mentioned earlier, however, increased PA has been associated with 
experiencing less pain, and also improved pain tolerance [21], indicating that the relationship may be 
bidirectional to some degree. Also somewhat predictably, an increased number of positive life events 
has been shown to relate to an increase in PA, though interestingly increased negative events do not 
seem to predict decreases in PA [44,76]. This is a finding which may support theories that propose 
NA and PA are largely independent from one another. Lastly, relationships and interpersonal stress 
appear to play an important role in levels of PA. Zautra and colleagues [75] found that individuals 
with FM reported steeper declines in PA during weeks of high interpersonal stress compared to 
individuals with osteoarthritis (OA; a chronic pain condition characterised by inflammation of the 
joints). Moreover, an earlier study also suggested that individuals with FM were less likely to seek 
social support at times of stress compared to those with OA [73]. Conversely, Davis et al. [11] found 
that individuals with FM were just as likely to seek social support at times of increased pain as 
individuals with OA who were awaiting knee surgery, but that individuals with FM had smaller social 
networks characterised by more negative relationships.  
At the neurobiological level, research has indicated the role of the catecholamine and opioid 
systems in an individual’s ability to maintain higher levels of PA [22]. Moreover, wider research 
suggests that affiliative social relationships can alter an individual’s pain threshold, as well as their 
immune and digestive systems, and that these changes occur through oxytocin-opiate system [14]. 
Current research links the oxytocin-opiate system to social support in that oxytocin enhances the 
buffering effect of social support on stress responsiveness [29]. Given that FM is a pain syndrome, 
and that for individuals with FM lower levels of PA have been linked to increased interpersonal stress, 
it is possible that this system may be particularly relevant to FM.  
Given the burgeoning research interest into potential predictors of PA and outcomes of 
low/high PA in individuals with FM it is important to be clear if there is a distinct and consistent 
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deficit in PA in individuals with FM compared to other populations. As such, the purpose of this 
review is to systematically search and assess the existing literature to answer the question: Is there a 
deficit in PA in individuals with fibromyalgia relative to other pain conditions, general health 
conditions, and also the general population? 
 
 
2.3 Method 
 
Literature Review 
The following databases were searched from their inception until April 2014: PsycINFO, 
PubMed, Scopus, and Web of Knowledge2. Search terms were “positive affect” or “positive emotion” 
and “fibromyalgia”. The reference lists of retrieved articles that met inclusion criteria were also 
searched by hand for additional relevant studies.  
 
Study Selection 
All stages of the study selection and data extraction process were completed by the author and a 
second independent reviewer. Disagreements were resolved through discussion. Potentially eligible 
studies were first selected on the basis of the title and abstract. Studies were included if they:  
a. Included a study sample of individuals with fibromyalgia 
b. Investigated PA 
Studies were excluded on the following criteria: 
a. Individuals with FM were not analysed as an independent sample3 (e.g. mixed chronic pain 
groups) 
b. There was no control or comparison group 
                                                          
2 Now known as Web of Science. 
3 This only applied for comparing levels of PA as the variable of interest. Studies that analysed results for 
combined pain groups were included if they reported statistics on PA separately for FM participants and other 
sample populations.  
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c. Sample populations under 18 years of age 
d. Non-English language studies 
e. Non-peer reviewed work (e.g. unpublished theses) 
f. Intervention or experimental design studies4 
g. Papers that did not report empirical or novel findings e.g. review articles 
 
Data Extraction and Quality Assessment  
The following data were extracted from each paper: sample characteristics, how PA was 
measured, data analysis, mean PA scores for each study sample and the associated standard deviation, 
and lastly whether significant between-group differences in PA were reported. 
A quality assessment of the included studies was also conducted. It proved difficult to find an 
existing well-validated quality assessment tool for cross-sectional psycho-social studies. As such, the 
quality of the included studies was appraised using a purpose-designed quality assessment tool that 
captured the important variables to this review. Based on Newcastle-Ottawa Scale [71] and the 
STROBE [63], the following areas were assessed: 
a. How representative the FM sample was of the wider FM population 
b. Whether a power calculation was performed or sample sizes were otherwise justified 
c. The quality of the measure of PA 
d. How well the study controlled for any potential biases between groups 
e. The appropriateness of statistical analysis 
 
The findings of the quality assessment are reported in Table 2, the implications of which are 
discussed further in the discussion section of this review. 
 
  
                                                          
4 Intervention or experimental manipulation was considered a confounding variable to the natural occurrence 
of PA within an FM sample. 
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Figure 1. Flow Diagram of Study Selection.  
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Articles screened by title 
and abstract 
(n=209) 
Duplicates removed 
(n=176) 
Articles excluded 
(n=175) 
Full texts requested 
(n=34) 
Full texts reviewed and excluded: 
(n = 21) 
 FM not analysed separately from other 
populations (n = 6) 
 Do not report group differences in PA (n=6) 
 No validated measure of PA (n = 3) 
 Not peer-reviewed (n = 3) 
 Review article ( n = 1) 
 No comparison group (n=1) 
 Unavailable (n = 1) 
 
Eligible articles 
(n=13) 
Not enough data reported 
(n=1) 
Articles included for 
review 
(n=12) 
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2.4 Results 
 
The literature search retrieved 385 citations (PsycINFO 74, PubMed 75, Scopus 97, Web of 
Knowledge 139). The initial screening of titles and abstracts revealed that 176 were duplicates and a 
further 175 were not relevant to the study based on the aforementioned inclusion and exclusion 
criteria. Full text articles were requested for the remaining 34 citations. Twenty-one were excluded for 
reasons stated in Figure 1, leaving 13 studies which were eligible for inclusion. During the review 
process, a further study [2] was excluded. Although the study stated that it found significantly lower 
PA in women with FM compared to women with rheumatoid arthritis (RA) and healthy women, the 
paper did not report the group means, standard deviations or any further information regarding data 
analysis. As such the decision was made to exclude the study due to lack of relevant information, 
leaving 12 studies included in the review. There was complete agreement between the author and 
second reviewer about which studies should be included for review. 
 
Study Characteristics 
Table 1 summarises the key characteristics of the studies included in the review. FM Sample 
sizes ranged from 20 to 403, with a total of 1,075 participants with FM. Only 2 of the 12 studies 
[27,28] included male patients (n=16), representing 1.5% of the FM sample. The overall mean age of 
the FM sample was 52.81 years (mean age range 40.60 to 62.00 years). Four studies reported the 
average duration of FM, which ranged from 4.86 years to 13.70 years [27,35,60,76]. 
Eight studies [11,23,35,47,74-77] included OA comparison samples (total n=404). Of these 
eight studies, one study [23] included an additional separate sample of individuals with a dual 
diagnosis of FM and OA (n=101), and one study [11] had an additional separate group of OA 
participants specifically awaiting knee surgery (n=29). Two studies [22,57] had samples of 
participants with RA (total n=117), one study [28] reported a heterogeneous physical health sample 
(e.g. arthritis, Lyme disease, neuropathy; n=92), and the final two studies [4,60] included healthy 
control groups (HC, n=216). 
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When assessing PA, eight of the 12 studies used the Positive and Negative Affect Schedule 
[PANAS, 69]. The PANAS is a 20-item measure, consisting of two subscales that assess PA and NA. 
Participants are asked to rate the extent to which they have experienced 20 mood adjectives (e.g. 
interested, afraid) on a scale from 1 (very slightly) to 5 (extremely). A further three studies used the 
expanded version of this scale, the PANAS-X [68]. The PANAS-X contains the same PA and NA 
subscales as the PANAS, as well as additional basic emotion subscales. Of the 11 studies that used 
versions of the PANAS, nine reported group PA scores reflecting participants’ average item score (out 
of 5), whereas the remaining two studies [4,28] reported group PA scores based on participants’ total 
PA subscale scores (out of 50). The final study used the Mood Adjective Checklist [17]. Similar to the 
PANAS, nine mood adjectives, four PA and five NA, are scored on a 7-point scale from 0 (not at all) 
to 6 (extreme). 
Six of the studies were cross-sectional. The remaining studies measured PA by taking 
multiple measurements over periods spanning two days to 12 weeks and reported the average PA 
scores for this period (see Table 1). 
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Table 1. 
 Study Characteristics and Outcomes. 
Study PA measure Study design Groups N  Mean age 
(years) 
PA means (SD) P ES 
[4] Becerra-
Garcia 2014 
PANAS Cross-sectional 
FM 
HC 
20 
20 
52.59 
55.11 
22.53 (8.82) a 
30.30 (5.10) a 
 
<.05 
 
1.08 
[11] Davis 
2001 
PANAS Cross-sectional 
FM 
OA 
OA surgery 
50 
22 
29 
62.00 
64.68 
64.83 
3.05 (0.70) 
3.38 (0.79) 
3.45 (0.72) 
 
< .05 
< .05 
 
0.45 
0.60 
[23] Finan 
2009 
PANAS 
Longitudinal   
(30 daily 
measurements) 
FM 
OA only 
FM/OA 
53 
106 
101 
52.51 
59.83 
56.74 
2.50 (0.80) 
2.63 (0.72) 
2.29 (0.80) 
 
n.s. (FM vs OA) 
n.s. (FM vs FM/OA) 
< .01 (FM/OA vs OA)  
 
- 
- 
0.45 
[27] Hamilton 
2007  
Mood 
Adjective 
Checklist 
Longitudinal  (12 
measurements 
over 2 days) 
FM 
RA 
22 
27 
48.22 
53.87 
2.22 (0.89) 
2.49 (1.05) 
 
n.s. 
 
- 
[28] Hassett 
2008 
PANAS Cross-sectional 
 
FM 
Mixed health 
 
79 
92 
40.60 
45.20 
29.10 (8.40)a 
33.80 (6.90) a 
 
<.01 
 
0.63 
[35] Kratz 
2007 
PANAS 
Longitudinal  
(10-12 weekly 
measurements) 
FM 
OA 
75 
35 
54.57 b 
 
2.59 (0.57) 
3.13 (0.55) 
 
Not stated 
 
0.96 
[47] Nicolson 
2010 
PANAS-X 
Longitudinal (30 
daily 
measurements) 
FM 
OA 
35 
35 
53.50 
58.40 
2.10 (0.60) 
2.70 (1.10) 
 
.02 
 
0.68 
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Table 1. 
 Study Characteristics and Outcomes. 
 
Note. PANAS (-X) = Positive and Negative Affect Schedule (Expanded); FM = fibromyalgia, OA = osteoarthritis, OA surgery = osteoarthritis patients 
awaiting knee surgery; RA = rheumatoid arthritis, FM/OA = participants with a dual diagnosis of fibromyalgia and osteoarthritis; HC = healthy controls; 
Mixed health = group of individuals with a range of different physical health conditions; ES = effect size. 
a Denotes mean group PA subscales scores (out of 50). All other studies report mean group PA scores as an average item score (out of 5). 
b Mean age in this study was reported as a single combined mean of the FM & RA groups.
Study PA measure Study design Groups N  Mean age 
(years) 
PA means (SD) P ES 
[60] van 
Middendorp  
2008 
PANAS-X Cross-sectional 
FM 
HC 
403 
196 
46.50 
45.60 
3.17 (0.64) 
3.47 (0.51) 
 
<.01 
 
0.50 
[74] Zautra 
2007 
PANAS 
Longitudinal  (30 
daily 
measurements) 
FM 
OA 
RA 
90 
76 
89 
55.20 
59.10 
52.30 
2.20 (0.60) 
2.80 (0.90) 
2.80 (0.60) 
 
< .05 
< .05 
  
0.80 
1.00 
[75] Zautra 
2005a 
PANAS-X 
Longitudinal  (12 
weekly 
measurements) 
FM 
OA 
87 
39 
52.68 
58.87 
2.67 (0.77) 
3.33 (0.65) 
 
<.01 
 
1.00 
[77] Zautra 
2005b 
 
PANAS-X 
Longitudinal (10-
12 weekly 
measurements) 
FM 
OA 
86 
38 
52.76 
59.38 
2.78 (0.58) 
3.16 (0.55) 
 
<.01 
 
0.67 
[76] Zautra 
1999 
PANAS Cross-sectional 
FM 
OA 
50 
52 
62.31 
65.34 
2.84 (0.65) 
3.19 (0.66) 
 
<.05 
 
0.53 
 
20 
 
  
 
Evidence for a Positive Affect deficit in Fibromyalgia 
Of the eight studies that compared FM and OA samples, seven found that individuals with 
FM had significantly lower PA compared to those with OA [11,35,47,74-77]. One of these studies 
also found that individuals with FM reported significantly lower PA compared to individuals with OA 
who were awaiting knee surgery. The surgery group was specifically included as a third comparison 
group as it was hypothesised the level of pain reported by this group would be comparable to those 
with FM (more so than the OA only group). Furthermore, one of the studies using the PANAS-X 
reported additional findings that that individuals with FM also scored significantly lower on the 
joviality, self-assurance and attentiveness subscales than individual with OA. 
The remaining OA study [23] compared individuals with FM only, individuals with OA only, 
and individuals with a dual diagnosis FM and OA (FM/OA). This study reported that the FM group 
did not statistically differ on levels of PA from either the OA only, or the FM/OA groups. However, 
the FM/OA did report significantly lower PA compared to the OA only. 
Two studies compared FM and RA groups. The first also found a significant deficit in PA for 
individuals with FM [74], whereas the second study did not [27]. Of note, the study that found no 
significant difference between groups had one of the smallest sample size, and it is unclear which 
statistical test was used to compare the groups. 
Both of the studies that used healthy control samples found that individuals with FM reported 
significantly lower levels of PA. The study by Becerra-Garcia et al. [4] was relatively small with 20 
participants in each group. In contrast, van Middendorp and colleagues [60] compared a large FM 
sample to healthy controls using the PANAS-X. In this study, a conservative p value of .01 was used 
to account for the large sample and multiple testing. Again, individuals with FM reported significantly 
lower levels of PA. Moreover, the expanded version of the PANAS also revealed that individuals with 
FM reported significantly lower joviality and self-assurance compared to the HC control group. There 
was no group difference for levels of attentiveness.  
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Lastly Hassett et al. [28] found that individuals with FM reported significantly lower levels of 
PA compared to a heterogeneous control group of individuals with a variety of physical health 
conditions. Similar to the previous study adjusted p values were calculated where necessary to 
account for multiple comparisons.  
 
Size of Group Differences 
Cohen’s d Effect Sizes (ESs) were also calculated to assess the magnitude of the deficit in PA 
for individuals with FM. This was done using the formula proposed by Borenstein and colleagues [6]. 
One study [23] did not report the Standard Deviation (SD) of the group means which was needed to 
compute ES, but this was calculated using the reported Standard Error (SE) and sample size. 5 
Traditionally, between group ESs are defined according to Cohen’s [8] classification; where ES of 
0.2, 0.5 and 0.8 represent small, medium and large group differences respectively. Table 1 shows the 
ESs across all studies when exploring group differences in PA between individuals with FM and the 
respective control groups. In this review, the smallest reported ES was 0.45, between individuals with 
FM/OA, and those with OA only [23]. The largest ES was 1.08, between an FM and an OA sample 
[4]. Two studies reported small to medium ES [11,23], six studies reported medium to large ES 
[11,28,47,60,76,77] and four reported large ES [4,35,74,75]. 
 
                                                          
5 SD = SE x √N 
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Table 2.  
Quality Assessment. 
 
Study Representative 
Sample 
Power 
calculation 
Controlled 
for group 
bias? 
Validated 
PA 
measure 
Main or  
preliminary 
outcome 
Appropriate 
statistical 
analysis 
Evidence of bias 
[4] Becerra-
Garcia 2014 
Yes 
None 
reported 
Partial Yes Main 
Yes 
t-tests 
Small sample size. 
No male participants. 
Examined if there were group differences in 
demographics but did not consider the possibility of other 
influencing extraneous variables e.g. pain.  
[11] Davis 
2001 
Unclear 
None 
reported 
No  Yes Main 
Yes  
ANOVA 
No male participants. 
Participants not excluded from FM group if they had OA 
too.  
Did not control for group differences in pain, general 
health, physical functioning or mental health. 
[23] Finan 
2009 
Unclear Yes Partial Yes Preliminary 
Unclear  
not stated  
No male participants. 
Creation of a combined FM/OA group not justified. 
Does not specify f-statistic test used.  
Controlled for differences in pain and age, but not 
education (which predicted PA). 
[27] Hamilton 
2007  
Yes 
None 
reported  
No  Yes Preliminary 
Yes 
t-test  
Did not control for differences in age, length of illness, 
pain or sleep quality. 
[28] Hassett 
2008 
Unclear Yes Yes Yes Main 
Yes  
ANOVA 
No male participants. 
Both groups drawn from larger sample of Lyme Disease 
study.   
Controlled for age, sex, education and marital status. 
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Table 2.  
Quality Assessment. 
 
 
 
Study Representative 
Sample 
Power 
calculation 
Controlled 
for group 
bias? 
Validated 
PA 
measure 
Main or  
preliminary 
outcome 
Appropriate 
statistical 
analysis 
Evidence of bias 
[35] Kratz 
2007 Unclear 
None 
reported 
No Yes Preliminary 
Unclear   
not stated  
No male participants. 
Participants not excluded from FM group if they had OA 
too.  
Did not control for differences in average pain or pain 
catastrophising. Unclear if there were significant 
differences in age, length of illness, sleep quality and 
fatigue. 
[47] 
Nicolson 
2010 
Unclear 
None 
reported 
No Yes Preliminary Chi-square 
No male participants. 
Participants not excluded from FM group if they had OA 
too.  
Did not control for differences in age, pain or depressive 
symptoms. 
[60] van 
Middendorp  
2008 
Yes 
None 
reported 
Partial Yes Preliminary 
Yes 
MANCOVA 
Controlled group differences in education and marital 
status, but not medication history. 
[74] Zautra 
2007 
Unclear 
None 
reported 
No 
 
Yes Preliminary 
Unclear   
not stated  
No male participants. 
Participants not excluded from FM group if they had OA.  
Does not specify f-statistic test used. 
Did not control for group differences in age, fatigue or 
depression. 
RA group completed paper diaries. FM and OA 
electronic diaries. 
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Table 2.  
Quality Assessment. 
 
Note. FM = fibromyalgia, OA = osteoarthritis, OA surgery = osteoarthritis patients awaiting knee surgery; RA = rheumatoid arthritis,  
FM/OA = participants with a dual diagnosis of fibromyalgia and osteoarthritis; PA = positive affect.
Study Representative 
Sample 
Power 
calculation 
Controlled 
for group 
bias? 
Validated 
PA 
measure 
Main or  
preliminary 
outcome 
Appropriate 
statistical 
analysis 
Evidence of bias 
[75] Zautra 
2005a 
Unclear 
None 
reported 
Yes  Yes Main 
Yes 
MANOVA 
No male participants. 
Participants in both groups could have other conditions as 
long as FM or OA was ‘worst’. 
Controlled for differences in age and pain. 
[77] Zautra 
2005b 
 
Unclear 
None 
reported 
No  Yes Preliminary 
Yes  
t-test 
No male participants. 
Participants not excluded from FM group if they had OA 
too.  
Did not control for group differences in age, neuroticism, 
pain or interpersonal stress. 
[76] Zautra 
1999 
Yes 
None 
reported 
Yes Yes Preliminary 
Yes  
ANOVA 
No male participants. 
Controlled for differences in age and pain. 
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2.5 Discussion 
 
The aim of this present study was to systematically review the evidence that suggests 
individuals with FM demonstrate a deficit in PA. The key findings from 12 studies were extracted and 
appraised. In summary, 11 of the 12 studies found evidence of a deficit in PA, specific to the FM 
population. It can therefore be inferred with a degree of confidence that this is a consistently present 
phenomenon.  The single study which failed to replicate this finding [27], had considerably smaller 
sample sizes than all but one of other studies which may have meant it was insufficiently powered to 
detect the presence of any statistically significant effects. Moreover, it was the only study to use the 
Mood Adjective Checklist [17] to measure PA, as opposed to the more widely used PANAS [68,69]. 
It is possible that the Mood Adjective Checklist does not measure the PA construct as well as the 
PANAS as it only uses 4-items to measure PA, and it has been suggested the items conflate PA/NA 
with the concept of pleasantness/unpleasantness [64]. 
Notably, the findings showed evidence of a deficit in PA in individuals suffering from FM 
which was consistent in relation to a range of comparison populations. The most commonly used 
comparison group was individuals with OA [11,23,35,47,74-77]. This makes sense as OA is also a 
long term pain condition, characterised by pain flare ups. That individuals with FM consistently report 
lower PA than those with OA, and also RA [74], is further evidence that the deficit is specific to the 
FM population, as opposed to chronic pain conditions more widely. Moreover, Hassett and colleagues 
[28] purposely used a control group made up of individuals with a whole range of physical health 
conditions in an attempt to match the groups with regards to levels of pain, fatigue, the effect of 
having long term symptoms and the need to frequently seek health care. This review also suggests the 
deficit is apparent when comparing individuals with FM to the general population [4,60]. 
A final key finding of this review is that it extended the existing data by calculating and 
reporting ESs relating to the magnitude of group differences in PA. It is important to go beyond 
examining for statistical significance and to consider the clinical significance of significant effects. 
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This additional analysis revealed that the majority of group differences produced medium-to-large 
ESs.  
 
Clinical Implications 
It is necessary to consider the findings of this review within the context of their potential 
clinical relevance. The many potential health benefits of increased positive affect, and related 
concepts such as well-being, were outlined in the introduction to this paper. In general, people who 
report an increase in positive emotions and well-being live longer and are also less likely to develop a 
range of health conditions [15,16]. In a comprehensive review synthesising cross-sectional, 
experimental and longitudinal data, Lyubomirsky and colleagues reported that increased well-being 
and PA “preceded success” in that happier people were more likely to gain employment and have 
higher job satisfaction, enjoy meaningful social support and higher relationship satisfaction, report 
fewer physical health problems and cope better with distress [39]. When focusing in on the FM 
population in particular, individuals with FM who report higher PA tend to experience pain less 
frequently [77] as well as exhibit a higher tolerance for pain when it is present [21,61], experience less 
NA, be less likely to have co-morbid psychiatric difficulties [28] and also report better general 
physical functioning [61]. Thus, finding that individuals with FM consistently report lower levels of 
PA than other pain and physical health population as well as healthy controls, and that the size of this 
deficit is considerable in magnitude is of clear importance. 
As with any research, this review must be considered within the context of its potential 
limitations. The limitations of the studies included in the review shall be addressed first, followed by 
the limitations of the review itself. 
 
Limitations of Study Quality 
First, as can be seen in Table 2, the degree to which the FM samples were truly representative 
of the FM population as a whole is not clear, as the samples were potentially confounded by a number 
of factors. Seven studies compared individuals with FM to those with OA; however, four of these 
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studies included individuals with a dual diagnosis of FM and OA within the FM sample, as long as 
individuals reported that FM caused them most difficulty [11,35,74,77]. In contrast, one study [23] 
created a completely separate group of individuals with both FM and OA and then compared them to 
FM only and OA only samples. None of these studies included rationales to justify their design and 
methodology. This may impact on the degree to which it can be confidently inferred that deficits in 
PA are specific to individuals with FM compared to the wider pain population as whilst the dual 
diagnosis FM/OA group reported significantly lower PA than the OA only group, the FM only group 
did not. It may be the accumulation of chronic pain disorders, rather than FM specifically that has an 
impact on PA. However, if this were true, it would be expected that the FM/OA group also reported 
significantly lower PA than the FM only group, which they did not. 
Moreover, Hassett et al. [28] took their sample from a larger trial of individuals with Lyme 
Disease (LD). The FM group were individuals who had recovered from LD and met the criteria for 
FM. The control group of individuals who met criteria for a range of physical health conditions was 
also drawn from the larger sample of the LD study. So, whilst the bias of having had LD was 
consistent across groups, the FM sample may have differed from the FM population ‘norm’ due to 
experiencing a recent episode of LD. Similarly, Zautra and colleagues [75] reported that the presence 
of other health conditions did not preclude individuals from being included in their FM sample, but 
provided no data on the types or frequency of such conditions to assess whether this biased the sample 
in any way. Furthermore, only 1.5% of the total FM sample across all studies were male. Although 
FM predominantly affects women, the figures from FM prevalence studies [46] suggest that male FM 
sufferers are considerably under-represented in this review.  
Second, only three studies reported having performed a power calculation to ascertain the 
necessary sample sizes to ensure adequately powered studies. Whilst some were clearly likely to have 
sufficient numbers for the analysis [e.g. 28], others were probably underpowered [e.g. 27]. Moreover, 
a number of studies used considerably unequal sample sizes which may also affect the results [e.g. 
11,35]. 
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Third, there were several issues relating to the analyses used. Three of the ten studies 
[23,35,74] failed to report what analysis they used to compare the groups when assessing for PA 
deficits. Moreover, a number of studies failed to control for other study variables that differed 
between samples, such as reported levels of pain. Six studies did not report controlling for any study 
variables which may have confounded group differences in PA, and a further three controlled for 
some, but not all potential confounding variables. Table 2 provides further details on the potentially 
confounding variables. These limitations may be linked to the fact that exploring group differences in 
PA was not the main outcome in the majority of studies, but rather a preliminary stage before a more 
thorough analysis relating to the studies main aims.  
Fourth, all of the studies used validated measures of PA, with 11 of the 12 using the PANAS 
or PANAS-X. This has both advantages and disadvantages. The common assessment method made it 
easier to compare and summarise the findings of the studies both within the context of this review and 
also the wider literature base where the PANAS appears to be the dominant method of assessing PA. 
Furthermore, it strengthens the confidence with which it can be said that individuals with FM 
consistently report lower PA compared to a range of different control groups assessed in the different 
studies, as they have all been assessed in the same way meaning there is no between-study 
measurement variance. However, reliance on a single measure can leave results open to flaws and 
biases of that measure. This potential limitation is considered unlikely though, as the PANAS is a 
well-validated, theoretically-derived measure. It is important to note that the only study not to report a 
significant deficit in PA within an FM sample [27] used a different measure, the Mood Adjective 
Checklist. This could reflect the methodological limitations of the study, such as small sample sizes 
and failing to control for potentially confounding variables. Alternatively, the difference in findings 
may reflect that either the PANAS or Mood Adjective Checklist does not measure PA well or that 
they measure PA based on different constructs. 
Finally, a potential limitation of this studies included in this review, is that eight of the 12 
studies were reported by the same research group [11,35,47,74-77]. Though not explicitly stated, there 
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is a possibility that the samples reported within these studies could overlap to some extent. This would 
mean that the total sample in this review is not only smaller than reported, but that some of the results 
could be in part a repetition of the same finding, which could greatly bias the overall review findings. 
Whilst this is a conservative speculation, similarities in recruitment methods and geographical 
location mean that it is important to consider. 
 
Review Limitations 
Limitations of the review process must also be acknowledged. The search strategy and 
applied exclusion criteria used may have resulted in the omission of relevant evidence. The practical 
decision was made not to include non-English language papers. This largely limits the generalizability 
of the findings to individuals from white, western cultures. In addition to this, only published findings 
were included which potentially leaves the review open to the so-called ‘file drawer’ bias. Studies that 
find significant results tend to be more readily publishable than those that do not, potentially inflating 
the size of the reported significant results. 
The review also chose to focus solely on identifying a deficit in PA within the FM population, 
to the exclusion of looking at NA.  This decision was made based on the combination of a number of 
factors. Firstly, the evidence base points to the relative independence of NA and PA, which would 
imply that they are likely to make unique contributions to outcomes in the FM population. This has 
been supported by findings that within FM, NA and PA load on to separate factors (referred to 
“vulnerabilities” and “resources” by researchers) that independently predict different outcomes [61]. 
Secondly, the research tradition for focusing on the presence of distress is well-documented, whereas 
the investigating presence of positive psychosocial resources and their implications remains less clear. 
Lastly, the Dynamic Affect Model [73,78] may suggest that the proposed changes in the relationship 
between NA and PA are best conceptualised as a relative drop in PA as opposed to an increase in NA. 
This is supported by the fact that, whilst 12 studies in this review also reported group differences in 
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NA,  only 5 studies found individuals with FM reported significantly higher levels of NA than the 
other study populations [4,60,74,76].  
 
Future Research 
This review points towards three key paths of future research. The first is the need for well 
controlled, high quality studies to better assess the true presence and magnitude of deficits in PA 
specific to the FM population. The majority of studies reported here investigated group differences in 
PA as a preliminary analytical step prior to main analyses of the studies respective aims and 
hypotheses. As a result, methodological rigour was somewhat lacking, or at best, not reported for the 
sake of brevity. Future research should be designed specifically for the purpose of investigating group 
differences in PA, with stringent methodology regarding inclusion and exclusion criteria for FM and 
comparison groups as well as appropriate analytical methods to minimise biases. Furthermore the 
inclusion of samples that include more men with FM, and that better represent non-western cultures, 
would strengthen the research base. 
Next, future research would benefit from an investigation of the mechanisms through which 
higher PA leads to better outcomes. Several studies reviewed here indicate that PA may be an 
important predictor of the common symptoms of FM including pain, fatigue, physical functioning and 
negative affectivity [28,61,74,75,77]. What is less clear is the path through which PA may affect these 
symptom variables. One study [77] did specifically tested whether a long-term disposition towards 
levels of PA are predictive of better outcomes, as specified by the Broaden-and-Build hypothesis [24], 
or whether the ability to specifically maintain higher levels of PA during critical periods (e.g. pain 
flare ups) is more predictive of better outcomes as per the Dynamic Affect model [73,78]. However 
the findings have failed to conclusively support one theory over the other. Further investigation on 
why and how increased levels of PA are more beneficial to individuals with FM should be 
undertaken.  
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Another direction for future research is to explore how clinical interventions may be used to 
increase PA, and thus improve service users’ well-being. There are already studies that suggest 
mindfulness-based interventions may be effective in increasing levels of PA for people with chronic 
pain [79]. This is supported by the findings of Kratz et al. [35] that increases in pain acceptance 
directly predicts higher levels of PA, and mediates the relationship between pain and NA, possibly 
through its influence on PA. Mindfulness promotes adopting “a particular orientation toward one’s 
experiences in the present moment, an orientation that is characterized by curiosity, openness, and 
acceptance” [5].  
Further exploration of how the two concepts are related, and if practice in mindfulness can 
bring about changes in PA should be investigated. Additionally, as the theory behind the benefits of 
PA arise from positive psychology, it is logical that this area may lead to the development of effective 
interventions as well. A recent meta-analysis of positive psychology interventions (PPIs) indicated 
that PPIs were an effective way of enhancing individuals’ subjective well-being, and also reducing 
depression. Subjective well-being can be defined as “a person’s cognitive and affective evaluations of 
his or her life” [19], and therefore PA is a major part of this construct. Indeed, the traditional method 
of measuring subjective well-being has been to create a composite score by using the PANAS to 
measure affective evaluation of one’s life, and the Satisfaction with Life Scale [18] to measure the 
cognitive evaluation. Hope has long been established to be a major predictor of subjective well-being 
[53,54]. Thus, PPIs that specifically aim to promote hope may be particularly successful in cultivating 
PA.  
What is more, in the UK, there is a particular drive within healthcare to promote the self-
management of long-term conditions such as FM [13]. A key part of this policy is the Expert Patient 
Program [12], based on Lorig and colleagues’ Chronic Disease Management Programme [37,38]. The 
Expert Patient Programme specifically emphasises goal setting and positive thinking which is 
compatible with a PPI approach. Studies that examine the way in which traits such as mindfulness and 
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hope relate to PA, as well as closely related constructs such as subjective well-being, would be a 
useful preliminary step in the development of interventions that aim to increase PA. 
 
Conclusion 
In conclusion, the results of this review have clearly demonstrated that individuals with FM 
consistently report a deficit in PA, a psychological resource well-known to be associated with a range 
of health benefits as well as wider positive outcomes related to social relationships and work. It is 
clear then, that when treating people with FM, assessing an individual’s general levels of happiness 
and well-being should be part of routine clinical work.  Moreover, interventions that focus on how to 
increase PA and well-being may be an effective alternative or complimentary approach to traditional 
symptom management for those individuals with FM reporting low PA. To aid this process, future 
research should in part focus on developing a better understanding of the mechanisms through which 
increased PA brings about health benefits for individuals with FM. Furthermore, resources should be 
invested in the design and trials of theoretically-driven interventions that aim to increase PA and well-
being. 
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3.1 Abstract 
 
Subjective well-being (SWB) is associated with a range of beneficial outcomes in those with physical 
health conditions. Yet the promotion of well-being is consistently neglected within healthcare settings 
in favour of the traditional focus on symptom reduction. Fibromyalgia (FM) is a chronic pain 
condition for which conventional treatment approaches have had limited success regarding consistent 
symptom management. The present study aimed to investigate whether: (i) goal-focused hope and 
mindfulness contributed to the promotion of SWB in the FM population, and (ii) whether higher SWB 
predicted improved FM-related outcomes. A total of 936 individuals with FM completed an online 
questionnaire study. Structural equation modelling tested the validity of a pre-specified hypothetical 
model of the relationships amongst study variables. SWB was found to significantly predict better 
FM-related outcomes and accounted for a substantial proportion of the total variance in this outcome. 
A model whereby mindful acceptance and hope both significantly predicted SWB, with decentering 
as a partial mediator to these relationships, was found to be an adequate fit, but results suggested that 
the model could be improved. These results indicate that SWB plays a key role in the experience of 
FM symptoms and therefore efforts to improve SWB should be a part of routine clinical practice 
alongside established symptom reduction approaches. Interventions that aim to promote SWB via 
enhancing mindfulness and hope maybe successful in this pursuit, but further research is needed to 
clarify the mechanisms through which these traits lead to better SWB. 
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3.2 Introduction 
 
Fibromyalgia (FM) is a chronic pain syndrome of unknown pathology [45]; for which no 
single drug regimen nor psychological intervention is of consistent benefit [1,38,42]. Recently, there 
is growing interest in the contribution of positive psychological traits to health outcomes [41]. Well-
being is more than just the absence of distress, as a lack of psychological distress does not guarantee 
the presence of well-being [26]. Research has indicated the presence of separate neural pathways 
within the brain for well- and ill-being [12,40]. Subjective well-being (SWB) is “a person’s cognitive 
and affective evaluations of his or her life” [16]. The evidence suggests that individuals who have 
higher SWB enjoy a range of beneficial health outcomes including increased longevity and immunity 
[13,14]. As such, it is clinically relevant to investigate which intrapersonal factors contribute to SWB 
specifically within the FM population, where effective treatments are somewhat limited. 
Both goal-focused hope [36,39] and mindfulness [6,7,33] have been identified as contributors 
to SWB. Goal-focused hope consists of having the motivation and self-belief in one’s ability to plan 
how to achieve desired goals [36]. Mindfulness has been conceptualised as a process involving the 
capacity to sustain present moment awareness and acceptance and curiosity to one’s internal 
experiences [5]. Evidence suggests that Mindfulness-based interventions are an efficacious treatment 
for chronic pain, including FM [22,48].  
It has been proposed that mindfulness leads to improvements in well-being via increased 
decentering [21,34,35], which is a fundamental metacognitive shift in the ability to recognise one’s 
thoughts as thoughts, rather than necessarily true facts [21] (appendix A). Decentering may increase 
SWB by reducing depressive rumination [21,34], increasing openness to new experiences, and also by 
increasing awareness of the positive aspects of experiences that would have previously been 
interpreted as neutral [20]. The broaden-and-build hypothesis [19] suggests that in turn, higher SWB 
may be beneficial to those with FM in that experiencing times of well-being may expand an 
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individual’s “thought-action repertoire”, allowing for the accrual of a range of coping resources that 
can then be used in times of distress. 
As mindfulness is present-focused and non-judgemental, and goal-focused hope is future-
orientated and striving, intuitively the two concepts appear conflicting. Yet both contribute to SWB 
and, moreover, preliminary data suggests that they may in fact be strongly correlated (Marks, 
unpublished dissertation7). Given this, and the fact that decentering is proposed to be the mechanism 
of change in interventions other than mindfulness alone [21], it would be of interest to investigate how 
hope and decentering relate to each other. Therefore, the aim of this study is to investigate if goal-
focused hope and mindfulness predict SWB in the FM population, and if decentering mediates these 
relationships. 
 
Hypotheses 
1. Increased mindfulness will predict increased SWB; this will be mediated by increased decentering. 
2. Increased hope will predict increased SWB; this will be mediated by increased decentering. 
3. Increased SWB will predict fewer FM-related difficulties. 
 
 
3.3 Method 
 
Participants 
Participants were a sample of individuals with fibromyalgia living in the community. The 
inclusion criteria were: (i) a self-reported clinician-confirmed diagnosis of FM, (ii) being aged 18 
years or older, and (iii) being a resident of the UK. In total, 1171 individuals consented to take part in 
the study. Only those who completed all of the measures were included in the analysis, leaving 960 
participants. Of these, 24 of the respondents reported that they did not have a diagnosis of FM as 
                                                          
7 Marks, K. (2013). Hope, Flow, Mindfulness and Subjective Well-being: A study of relationships. Unpublished 
doctoral thesis, University of Liverpool: Liverpool. 
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confirmed by a medical professional. As such, they were excluded from the analysis. Therefore the 
final sample size was 936.  
The sample consisted of 873 women and 63 men. The mean age was 47.97 years old (SD 
10.82, range 19 – 82). In total, 80% (n = 753) of the sample were taking medication to manage their 
FM symptoms, and 28% (n = 260) had previously completed some form of mindfulness-based 
intervention. When asked about meditative practice, 66% (n = 621) of participants reported that they 
did not practice any kind of meditation, 15% (n = 144) of the sample had practiced meditation for less 
than a year, 9% (n = 81) had practised for one to five years, and 10% (n = 90) for five years or more. 
 
Measures 
Hope was assessed using the State Hope Scale [appendix B, 37]. Factor analysis supports a 
six-item measure which consists of three items measuring ‘pathway’: the ability to plan and perceive 
how one can attain one’s goals. An example item being: “If I should find myself in a jam, I could 
think of many ways to get out of it”. The remaining three items measure ‘agency’: the motivation and 
ability to pursue pathways to one’s goals. An example agency item is: “At the present time, I am 
energetically pursuing my goals”. Each item is Likert-rated from 1 (definitely false) to 8 (definitely 
true). The Cronbach’s alpha for the pathway and agency subscales in this sample were α = .82 and α = 
.89 respectively. 
Mindfulness was measured using the Philadelphia Mindfulness Scale [PHLMS; appendix C, 
10]. The scale was devised to measure mindfulness based on the operational definition devised by 
Bishop and colleagues [5]. Confirmatory factor analysis supported a 20-item structure measure 
consisting of two orthogonal subscales: awareness and acceptance. Each item is Likert-rated from 1 
(never) to 5 (very often). An example awareness item is: “I am aware of what thoughts are passing 
through my mind”, and an example acceptance item is: “I try to distract myself when I feel unpleasant 
emotions”. The Cronbach’s alpha in the present study was α = .79 for the awareness subscale and α = 
.85 for the acceptance subscale. 
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Decentering was measured using the decentering subscale of the Experiences Questionnaire 
[EQ; appendix D, 21]. It consists of 11 items measured on a 5-point Likert scale ranging from 1 
(never) to 5 (all of the time). An example item is: “I can observe unpleasant feelings without being 
drawn into them”. In its development, the EQ demonstrated good convergent and divergent validity. It 
was positively correlated with cognitive reappraisal, and negatively correlated with depressive 
rumination, experiential avoidance and emotional suppression.  Within the present sample, the 
Cronbach’s alpha was α = .87. 
As previously discussed, SWB refers to a person’s cognitive and affective evaluation of their 
life. Consistent with previous research [e.g. 16], the latent variable SWB was estimated through 
measuring life satisfaction as a cognitive evaluation of life, as well as exploring participants’ affectual 
experiences. 
Life satisfaction was measured using the Satisfaction with Life Scale [SWL; appendix E, 15]. 
It is a five-item measure of life satisfaction where each item is rated on a Likert scale from 1 (strongly 
disagree) to 7 (strongly agree). An example item is: “So far I have gotten the important things I want 
in life”. The measure was shown to correlate well with existing measures of SWB. In the present 
study, the Cronbach’s alpha was α = .87. 
Positive and negative affect was measured with the Positive and Negative Affect Scale 
[PANAS; appendix F, 43], which is a 20-item questionnaire consisting of two 10-item subscales that 
measure positive affect (PA) and negative affect (NA). The authors reported that a principal factor 
analysis supported the measurement of PA and NA as two independent factors.  Affect is measured by 
asking participants to rate the extent to which they have experienced a range of mood states during the 
past week on a Likert scale from 1 (very slightly) to 5 (extremely). Examples of PA mood states 
include “enthusiastic” and “inspired”, whereas, examples of NA mood states include “afraid” and 
“irritable”.  Cronbach’s alpha of PA and NA within this sample were both α = .91.   
 Finally the extent of FM-related difficulties and their impact were measured using the 
Revised Fibromyalgia Impact Questionnaire [FIQR; appendix G, 4]. The FIQR is a 21-item measure 
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comprised of three domains. Nine items measure functional status, for example: “fibromyalgia made 
it difficult to [brush or comb your hair]”, two items measure overall impact of FM, for example: 
“Fibromyalgia prevented me from accomplishing goals for the week”, and 10 items measure the 
presence of common FM symptoms, for example: “Please rate your level of [pain]”. Participants are 
asked to think about how FM has impacted on their life over the last seven days. For each domain, 
items are rated on an 11-point Likert scale ranging from 0 to 10, with higher scores indicating that 
their FM has had a greater impact on their life. The FIQR has demonstrated good discriminant validity 
in identifying those with FM from healthy controls, individuals with rheumatoid arthritis and 
individuals with lupus.  In this present study, Cronbach’s alpha for the functional, overall impact, and 
symptom domains were α = .93, α = .87 and α = .88, respectively. 
 
Procedure 
This was a cross-sectional internet-based study. Institutional and ethical approval was 
obtained from the University of Liverpool (see appendix H). The study was then advertised through 
two national fibromyalgia charities, who placed a brief description of the study and a link on their 
forums and social media pages. The link took participants to web page containing the participant 
information sheet, which described the aims and nature of the study in detail, and a consent form 
(appendix I and J respectively). Participants were informed that they could withdraw at any point 
during the study by closing the internet browser, or otherwise leaving the study page. It was made 
clear that incomplete responses would be deleted and not included in the final data set. 
Questions about demographic information and previous mindfulness-based interventions 
preceded the start of the questionnaires. Each measure was then presented on a separate page in the 
following order: SLW, PANAS, PHLMS, EQ, Hope Scale, FIQR. The FIQR was deliberately placed 
at the end as it was hypothesised that focusing participants’ attention on symptoms such as pain, 
fatigue and depression may have potentially negatively primed their mood. In total, participating in 
the study took approximately 15 minutes. A purposeful effort was made to keep participation time to a 
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minimum as FM symptoms can make it difficult for sufferers to sit in one place and concentrate for 
long periods of time. 
 
Analysis 
SPSS 21 was used to manage the data and for the preliminary analyses. This included 
exploring whether the data met the necessary assumptions for structural equation modelling (SEM), as 
well as analysing first-order correlations amongst study variables.  
SEM was then employed to test the studies main hypotheses using AMOS 20 [2]. The first 
stage of SEM is to construct a hypothesised model of the relationship amongst the variables of 
interest, a priori. SEM then works by estimating a covariance matrix based on the specified model. 
Next this estimated covariance matrix is compared to the covariance matrix generated from the 
observed data, to consider how well they “fit”. Model fit was determined via the chi-square statistic 
(χ2) which should be non-significant (p >.05). However the χ2 can be biased towards rejecting models 
in large sample sizes [9], hence the need to report it within the context of other fit indices. As per Hu 
& Bentler’s [25] recommendations, how well the hypothesised model fit the observed data was 
assessed using the following goodness of fit indices and cut offs: the Comparative fit index (CFI) > 
.95; the Root Mean Square-Error of Approximation (RMSEA) ≤.06; and the Standardised Root Mean 
Square Residual (SRMR) ≤ .08. See appendix K for a more detailed explanation of SEM analysis and 
fit indices.  
Consensus is lacking with regards to what is an acceptable sample size for SEM approaches. 
One proposed recommendation is that a minimum sample size of 200 is necessary [27]. Alternatively, 
another suggestion is that a minimum sample size should represent at least 10 participants per 
estimated parameter [32]. This paper will go onto present two SEM models. The first included 17 
parameters (eight regression weights, six error variances, three covariances) indicating a minimum 
sample size of 170. The second model consisted of 22 parameters (12 regression weights, six error 
variances, four covariances) indicating a minimum sample of 220. As the total sample size in this 
study is 936, it can be assumed that the analysis was adequately powered. 
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3.4 Results 
 
Data Screening 
The online questionnaire design did not allow participants to miss out questions and any 
incomplete responses were treated as withdrawals in line with the study’s protocol. Therefore there 
were no missing data. Initial data screening explored the normality and heteroscedasticity of the study 
variables. Normality was explored using histograms, which suggested that SLW (sk = .668), PA (sk = 
.47), both the pathway (ku = -.92) and agency (sk = .46) subscales of the hope scale, and all three 
subscales of the FIQR (function sk = -.71, overall impact sk = -.79, symptoms sk = -.60) were not 
normally distributed. Following log transformations, SWL and PA were normally distributed, 
however it was not possible to successfully transform the subscales of the hope scale or FIQR. Instead 
total scale scores were computed for these measures. The Total FIQR score appeared normally 
distributed and a log transformation of the total hope score resulted in a normally distributed variable.  
Heteroscedasticity occurs where the residuals are not uniformly distributed.  
Heteroscedasticity between variables can be a problem in SEM as it can undermine the assumption of 
multivariate normality [27]. The distribution of residuals were explored through a series of multiple 
regression analyses within which each of the endogenous variables (decentering, SLWS, PA, NA and 
FIQR) were entered as the dependent variable, and all the other model variables entered as predictor 
variables. The histograms of the regression residuals suggested normality. Some of the resulting 
scatterplots of predicted values versus residuals indicated that there was potentially a mild degree of 
heteroscedasticity amongst some of the variables. Given that the amount of heteroscedasticity was 
limited, and the sample size was very large, it was unlikely that this would contravene the 
assumptions of SEM [28]. For further information regarding data screening, see appendix L. 
 
  
                                                          
8 Figures in brackets report non-normal skewness (sk) and kurtosis (ku) statistics. 
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Descriptive Statistics 
Mean descriptive statistics for the key study variables are reported in Table 3.1. Male and 
female participants did not significantly differ on any of these variables (all p’s > .05). Individuals 
who were taking medication reported significantly higher levels of NA, t (934) = 3.47, p < .01, and 
FM-related difficulties, t (934) = 6.27, p = .04. Cohen’s d was used to examine the effect size (ES) of 
these differences. The ES was small for the group difference in NA (d = .23) and small-to-medium for 
FM-related difficulties (d = .41). There was no difference between participants who were taking 
medication and those who were not for the remaining study variables (all p’s > .05). To see how the 
means reported for this sample compare to existing normative means, please see appendix M. 
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Table 3.1.  
Descriptive Statistics. 
Variable Mean Standard Deviation Range 
SWL  
(SWL a) 
14.66 
(1.11) 
7.05 
(0.22) 
5 – 35 
(0.70 – 1.54) 
PA 
(PA a) 
23.35  
(1.34) 
8.45 
(0.16) 
10 – 48 
(1.00 – 1.68) 
NA 26.31 9.35 10 – 50 
Hope 
(Hope a) 
23.43 
(1.32) 
10.68 
(0.22) 
6 – 48 
(0.78 – 1.68) 
M’ful aware 36.48 5.94 13 – 50 
M’ful accept 25.31 6.60 10 – 50 
Decentering 33.02 6.96 14 – 55 
FM 68.54 18.52 5 – 100 
a denotes transformed variable.  The numbers in brackets represent transformed values. 
Note. SWL = satisfaction with life; PA = positive affect; NA = negative affect, M’ful aware = mindful 
awareness; M’ful accept = mindful acceptance; FM = fibromyalgia-related difficulties.  
  
Correlations 
Pearson’s correlations were calculated for all pairs of variables and are reported in Table 3.2. 
Hope and mindful acceptance were significantly correlated with all of the SWB variables as predicted. 
However, mindful awareness was only significantly correlated with PA. Hope, mindful acceptance 
and mindful awareness were each positively correlated with decentering. In turn decentering was 
significantly correlated with all of the SWB variables as predicted. All of the study variables, except 
for mindful awareness, were significantly correlated with the impact of FM-related difficulties. 
53 
 
  
 
Mindful attention and mindful acceptance were significantly negatively correlated. This is 
somewhat in line with past research [3] and will be addressed further in the discussion section. 
Unexpectedly, neither mindful attention nor mindful acceptance were significantly related to having 
previously received a mindfulness-based intervention (r = .06, p = .05 and r = .02, p = .56 
respectively), and only mindful awareness was significantly correlated to practicing meditation (r = 
.16, p < .01). 
Age was significantly associated with higher levels of PA, decentering and mindful 
acceptance, as well as lower levels of NA, though the correlations were relatively weak. Lastly, 
duration of FM symptoms was significantly associated with higher levels of PA, decentering and 
mindful awareness, lower levels of SWL, and increased FM-related difficulties. Again, all of these 
correlations were relatively weak. 
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Table 3.2.  
Correlation Matrix of All Study Variables. 
Variable 1 2 3 4 5 6 7 8 9 10 
1. SWL a           
2. PA a .45**          
3. NA -.46** -.39**         
4. Hope a .55** .65** -.53**        
5. M’ful aware .03     .22** -.01 .18**       
6. M’ful accept .30** .24** -.53** .32** -.23**      
7. Decentering .34** .52** -.47** .60** .42** .26**     
8. FM -.49** -.49** .55** -.57** -.06 -.36** -.36**    
9. Age -.02 .08* -.14** .06 .06 .08* .15** <.01   
10. Duration -.10** .07* -.04 .02 .14** -.02 .09** .12** .21**  
* Significant at .05 level, two-tailed. 
** Significant at .01 level. 
a denotes transformed variable.  For these variables the correlations reported reflect the relationship 
between the transformed variable and the other study variables. 
Note. SWL = satisfaction with life; PA = positive affect; NA = negative affect, M’ful aware = mindful 
awareness; M’ful accept = mindful acceptance; FM = fibromyalgia-related difficulties; Duration = 
duration since FM symptoms began. 
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SEM Analysis  
SEM was used to test a hypothesised model where decentering mediated the relationship 
between the mindfulness variables and SWB, as well as mediating the relationship between goal-
focused hope and SWB. The model also specified that increased SWB would result in fewer FM-
related difficulties. The Maximum Likelihood method was used to estimate the parameters of the 
proposed model based upon the data covariance matrix, χ2 = 798.62, p < .01, CFI = .74, RMSEA = 
.22, SRMR = .15. The χ2 was significant, indicating that the hypothesised model did not fit the exact 
data. This was expected due to the large sample size. However, further examination of the fit indices 
suggested that the model was indeed a poor fit (see section 3.3). The model complete with 
standardised and unstandardised regression weights, associated significance values, and R2 values are 
reported in figure 3.1. 
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Figure 3.1.  Graphical Representation of the Initial Proposed Model. 
Standardised regression slopes are depicted by single-headed arrows and covariance by curved 
double-headed arrows. The unstandardised regression weights are reported in the brackets. The total 
standardised proportion of variance accounted for (R2) is reported to the top right hand corner for 
each endogenous variable. 
** Significant at .001 level. 
 
Model Modification  
As the model was a poor fit, the modification indices were examined to ascertain how it could 
be improved, though it was important that any modifications were theory-driven [9]. The modification 
indices suggested adding direct paths from mindful awareness, mindful acceptance and hope to SWB 
would significantly improve the model fit.   
The initial model proposed that decentering fully mediated the relationships between hope 
and SWB, and mindfulness and SWB respectively.  The addition of indirect paths represented a 
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change from a full to a partial mediation model where each of the three predictor variables each 
contributes something unique to SWB directly as well. This seemed a reasonable modification to 
make as it did not drastically alter the original hypothesis regarding mediation. Similarly, the 
modification indices suggested an additional direct regression slope between decentering and FM 
symptomology would improve the model, again implying that the relationship is partially mediated by 
SWB, but that decentering contributes something unique to FM symptomology directly. The modified 
model estimated both the direct and indirect effects predictor variables had on dependent variables. 
Bootstrapping was used to generate confidence intervals to test whether the indirect effects were 
significantly different from zero [31]. In the current study, 5000 bootstrap iterations were conducted 
[18]. Finally, the residuals associated with NA and PA were allowed to covary in the model. This 
reflects a common measurement relationship in that PA and NA were both measured in the same way 
using the PANAS (unlike SWL). 
The modified model was also estimated using the ML approach, χ2 = 152.34, p < .01, CFI = 
.95, RMSEA = .11, SRMR = .05. Again the χ2 was significant indicating that the model was 
significantly different from the ‘perfect’ model, though again this may partly reflect the sample size. 
The CFI and SRMR indices indicated that the new model was a good fit. However, the RMSEA 
exceeded the cut-off of .06. The modified model was a significantly better fit than the original model 
(Δχ2 = 646.28, df = 5, p < .01). Interpreting the fit statistics together suggests that the model is an 
acceptable fit, but that there may be room for improvement. Further modifying the model at this stage, 
however, would be going beyond a clear theoretical rationale, and may result in over-fitting to the 
data set, limiting its generalisability. Figure 3.2 depicts the modified model with standardised and 
unstandardised direct effects, associated significance values, and R2 values.  
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Figure 3.2.  Graphical Representation of the Modified Model. 
Standardised regression slopes for direct effects are depicted by single-headed arrows and 
covariance by curved double-headed arrows. The unstandardised regression weights are reported in 
the brackets. The total standardised proportion of variance accounted for (r2) is reported to the top 
right hand corner for each endogenous variable. 
** Significant at .001 level. 
 
The standardised indirect effects are reported in Table 3.3.  In the modified model, all indirect 
effects were significantly different from zero, except for the indirect relationship between mindful 
awareness and SWB.  As suggested by McDonald and Ho [30], a matrix of observed covariances and 
residual covariances are reported in Appendix N. 
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Table 3.3.  
Standardised Indirect Effects for the Modified Model. 
Predictor Outcome Indirect Effect Lower CI Upper CI 
M’ful aware SWB .09** .06 .12 
M’ful aware FM <.01 -.05 .04 
M’ful accept SWB .05** .03 .06 
M’ful accept FM -.22** -.27 -.18 
Hope SWB .11** .08 .14 
Hope FM -..50** -.54 -.46 
Decentring FM -.20** -.25 -.14 
** Significant at .01 level, two-tailed. 
Note. M’ful aware = mindful awareness; M’ful accept = mindful acceptance; SWB = subjective well-
being, FM = fibromyalgia-related difficulties, Lower CI = lower confidence interval, Upper CI = 
upper confidence interval. 
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3.5 Discussion 
 
This study had three main aims: (i) to investigate if mindfulness predicted SWB, and whether 
this relationship was mediated by decentering; (ii) to investigate if hope predicted SWB, and whether 
this relationship was mediated by decentering; and (iii) to explore the importance of SWB on FM-
related symptoms. Both mindful acceptance and hope significantly predicted SWB, and that both of 
these relationships were partially mediated by decentering. In contrast, mindful awareness did not 
have any significant direct effect on SWB, nor did it have an indirect effect through decentering. 
Furthermore, the SEM model showed that SWB accounted for a significant amount of variance in 
FM-related difficulties, indicating that participants who had higher SWB reported fewer FM-related 
difficulties. 
That mindful acceptance significantly predicted SWB whereas mindful awareness did not, fits 
with past research. In developing the PHLMS, Cardaciotto and colleagues [10] found that the 
acceptance subscale was negatively associated with measures of depression and anxiety, whereas the 
awareness subscale was not. They concluded that the acceptance component of mindfulness may play 
a unique role in relation to mental health. The current study suggests that mindful acceptance may 
also have a distinct role in the promotion of well-being. Moreover, as in this study, Baer and 
colleagues also found that the “observe” and “accept without judgement” subscales of their 
mindfulness scale were negatively correlated [3]. They suggested for less experienced meditators, 
developing skills in present moment awareness of experiences may be associated with the tendency to 
be judgemental of these experiences, implying that acceptance may develop after or slower than 
awareness skills. Therefore, in individuals with chronic pain who have increased awareness of 
experiences related to pain without yet cultivating an accepting attitude, this increased awareness 
would not lead to increased SWB. 
It is an interesting finding that despite seemingly representing different ideologies, both goal-
focused hope and mindful acceptance predicted SWB, and the relationships were mediated by 
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decentering. Moreover hope was positively correlated with both mindfulness subscales. One possible 
explanation is that mindfulness and hope correlate because they map onto an underlying construct of 
Psychological Flexibility, which has been defined as the ability to be aware fully in contact with the 
present moment, and to persist in or change behaviour when doing so serves ones values [23,24]. 
Psychological flexibility is theorised as consisting of two broader over-arching factors. The first is 
mindfulness and accepting processes which includes: (i) cognitive defusion, the ability to recognise 
thoughts as thoughts and not immutable facts; and (ii) acceptance of distressing experiences as oppose 
to avoidance. The second factor is committed behaviour processes. This includes values that are freely 
chosen qualities that an individual considers important to how they wish to live their lives; and also 
the persistence with committed action that is consistent with living within ones values. It is often 
conceptualised as goal-driven, in that an individual will have behaviour goals that they can achieve, 
that allow them to act within their values. 
It is possible to see how the model presented in this study can be reconciled with the above 
definition of psychological flexibility. Mindful acceptance and decentering may be akin to the 
defusion and acceptance processes. Goal-focused hope maybe be akin to committed action process 
(e.g. “At this time, I am meeting the goals that I have set for myself”), as well as values (e.g. “Right 
now, I see myself as being pretty successful”). Mindful awareness as measured in this study would 
also seem to be akin to present moment awareness in the psychological flexibility model.  
As expected, increased SWB predicted reduced FM-related difficulties such as pain, fatigue, 
anxiety and depression. The model was further improved by adding a direct path between decentering 
and FM-related difficulties. Together, SWB and decentering accounted for a large amount of the 
variance in FM-related difficulties (54%). This finding is an important contribution to the existing 
literature in that, as far as the author is aware, it is the first study to look at SWB in the FM 
population. Given that it is well-documented that the presence of well-being is more than the lack of 
distress [26], this finding is of considerable importance.  
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Limitations  
There are several limitations to be acknowledged. Firstly, the goodness of fit indices 
suggested that the model was an acceptable rather than good fit and so the findings should be 
interpreted with caution. Modifying the model to better represent how the processes of psychological 
flexibility leads to change in SWB may be one way to improve the model fit. 
Secondly, although SEM tests theoretically-defined causal models, the data explored in this 
study was cross-sectional so the direction of the effects reported cannot be inferred with absolute 
certainty. It may be, for example, that fewer FM-related difficulties predicts higher SWB. 
Nonetheless, the model was consistent with theoretical reasoning based on existing literature. To be 
more confident of the direction of effects, longitudinal experimental studies are needed. Ideally this 
would involve trials of interventions designed to improve mindfulness and hope. Pre- and post- 
comparisons could then be used to see if increased mindfulness and hope lead to later increases in 
SWB and improvements in FM-related difficulties.  
Thirdly, the study used measures of state hope and state affect, rather than trait measures. 
This means the findings regarding hope and affect may have been influenced by how participants felt 
on the day as opposed to being a reflection of their general disposition. Both state and trait hope and 
state and trait affect have been shown to be highly correlated [37,43], but despite this, the distinction 
between state and trait affect may still be important. Within the context of chronic pain, the Dynamic 
Affect Model [46,47] would suggest that it is a person’s ability to maintain higher levels of state PA 
during times of pain that is important to coping. In contrast, the more established broaden-and-build 
hypothesis of positive affect [19], would suggest that consistently higher trait PA broadens ones 
“thought-action repertoire” allowing for the development of a range resources that are then available 
as coping skills at times of stress. Future research should investigate whether the findings of this paper 
are applicable to trait affect.  
 Fourthly, as data were collected online it was not possible to verify that participants met the 
inclusion criteria for the study, most notably a diagnosis of FM. Reasonable steps were taken to 
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address this. Inclusion criteria was made clear in the study advert, participant information sheet and 
consent form. Participants were also asked to confirm that they had received a formal diagnosis prior 
to completing the study measures. Moreover, the study was only advertised through FM charities. 
 Lastly, the study opted not to collect further demographic data on education and employment 
and marital status to reduce participation time. Although past research has suggested that 
demographic variables account for only a small proportion of the variance in SWB [17], it still may 
have been of benefit to control for demographic factors.  
 
Clinical Implications and Future Research 
This study has three main implications for clinical practice and future research. The first is the 
need to further investigate which factors are associated with promoting SWB in the FM population. 
This research suggests acceptance, goal-focused hope and decentering all contribute to SWB. SEM 
suggested that a model which hypothesised that decentering partially mediated the relationship 
between acceptance and hope and SWB was an adequate fit, but that there was room for 
improvement. Future research should instead seek to test the legitimacy of models specifically based 
on psychological flexibility.  
 The second implication is that clinicians working with individuals with FM should routinely 
assess their levels of SWB, and engage in interventions which aim to improve SWB where necessary. 
Psychological flexibility is at the heart of Acceptance and Commitment Therapy [24] so this would be 
the obvious intervention to consider. There is growing evidence that ACT is indeed an efficacious 
treatment for FM [44] as well as the wider chronic pain population [8,11,29]. 
 Lastly, measures of SWB should be included as a main outcome in studies that investigate the 
efficacy of interventions for FM. Studies which solely rely on measuring reduction in symptomology 
as a sign of effectiveness are not measuring the impact treatments may or may not have on well-being. 
This study has demonstrated that individuals with higher SWB reported less FM symptoms, including 
pain, fatigue, anxiety and depression, and also that FM had less of a debilitating impact on their lives. 
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Conclusion 
In conclusion, the present study is the first to show that increased SWB is associated with a 
significant reduction in reported FM-related difficulties. Moreover, SEM demonstrated that 
mindfulness, goal-focused hope and decentering were all significant contributors to the promotion of 
SWB within the FM population. A model whereby decentering mediated the relationships between 
goal-focused hope and SWB, as well as mindfulness and SWB proved to be an adequate but not good 
fit. This provides grounds for future investigation of precisely how these concepts bring about 
increased SWB, and thus how they might be utilised effectively in the treatment of FM. 
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Appendix A 
Defining and Distinguishing Mindfulness and Decentering 
 
Bishop and colleagues (2004) endeavoured to reach an operational definition of mindfulness 
in response to an existing lack of consensus within the research community. They arrived at a two-
faceted model. The first component is the capacity for the sustained self-regulation of attention which 
allows an individual to stay engaged in the present moment. The second component is the capacity to 
maintain an acceptance and curiosity to all of one’s thoughts, feelings and sensations.  
In comparison, in developing the Experience Questionnaire (EQ) as a measurement of 
decentering, Fresco et al. describe decentering based on Safran and Segal’s influential (1990) 
definition as: “ability to observe one’s thoughts and feelings as temporary, objective events in the 
mind, as opposed to reflections of the self that are necessarily true.” (Fresco et al., 2007 p. 234). 
Fresco and colleagues explicitly state that they do not see their definition (and subsequent EQ 
tool) as synonymous with mindfulness as defined above by Bishop et al. (2004); rather, they feel it is 
complimentary to it. They also note that Bishop and colleagues themselves consider mindfulness and 
decentering “within the same general domain” but without either being redundant. To clarify, 
mindfulness may enable an individual to focus on the thoughts in the present moment with acceptance 
and curiosity, but it is the process of decentering that specifically facilitates the individual to 
recognise that the thoughts they are noticing are just thoughts, as opposed to definite truths about the 
self. 
In summary, a plausible stance regarding the separateness of mindfulness and decentering 
based on the above would be that to engage with mindfulness may well lead to adopting a decentered 
stance, but to be decentered is not necessarily to be mindful as there appears to be other paths that 
lead to a decentered stance that do not involve mindful meditation.  Fresco and colleagues’ 
conceptualisation of decentering would imply that it is a mediating mechanism of change in both 
mindfulness- and cognitive-based therapies. Therefore, it would be reasonable to investigate 
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decentering as a mediator in the relationship between mindfulness and SWB. This would also fit with 
other existing models of change in mindfulness-based therapies that posit constructs akin to 
decentering, such as “metacognitive awareness” (Segal, Williams & Teasdale, 2002) and 
“reperceiving” (Shaprio, Carlson, Astin & Freedman, 2006) as the mechanism of change in 
mindfulness-based interventions 
In an attempt to minimise the potential for overlap in measurements of the two concepts, the 
Philadelphia Mindfulness Scale (Cardaciotto, Herbert, Forman, Moitra & Farrow, 2008) was 
specifically chosen as a measurement of dispositional mindfulness as it was constructed based on the 
Bishop and colleagues conceptualisation of mindfulness. As such, it is restricted to the measurement 
of two subscales that aim to measure the two defined facets: the capacity for the sustained self-
regulation of attention and the capacity to maintain an accepting and curious stance.  
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Appendix B 
State Hope Scale 
 
Read each item carefully. Select the response that best describes you. 
 
 
1. If I should find myself in a jam, I could think of many ways to get out of it. 
 
○ Definitely False 
○ Mostly False 
○ Somewhat False 
○ Slightly False 
○ Slightly True 
○ Somewhat True 
○ Mostly True  
○ Definitely True  
 
 
2. At the present time, I am energetically pursuing my goals. 
 
○ Definitely False 
○ Mostly False 
○ Somewhat False 
○ Slightly False 
○ Slightly True 
○ Somewhat True 
○ Mostly True  
○ Definitely True  
 
 
3. There are lots of ways around any problem that I am facing now.   
 
○ Definitely False 
○ Mostly False 
○ Somewhat False 
○ Slightly False 
○ Slightly True 
○ Somewhat True 
○ Mostly True  
○ Definitely True  
 
 
4. Right now, I see myself as being pretty successful.   
 
○ Definitely False 
○ Mostly False 
○ Somewhat False 
○ Slightly False 
○ Slightly True 
○ Somewhat True 
○ Mostly True  
○ Definitely True  
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5. I can think of many ways to reach my current goals. 
 
○ Definitely False 
○ Mostly False 
○ Somewhat False 
○ Slightly False 
○ Slightly True 
○ Somewhat True 
○ Mostly True  
○ Definitely True  
 
 
6. At this time, I am meeting the goals that I have set for myself. 
 
○ Definitely False 
○ Mostly False 
○ Somewhat False 
○ Slightly False 
○ Slightly True 
○ Somewhat True 
○ Mostly True  
○ Definitely True  
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Appendix C 
Philadelphia Mindfulness Scale  
 
Please circle how often you experienced each of the following statements within the past week.     
 
1.  I am aware of what thoughts are passing through my mind.   
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
 
 
2.  I try to distract myself when I feel unpleasant emotions.   
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
 
 
3.  When talking with other people, I am aware of their facial and body expressions.    
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
 
 
4.  There are aspects of myself I don’t want to think about.   
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
 
 
5.  When I shower, I am aware of how the water is running over my body.   
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
 
 
6.  I try to stay busy to keep thoughts or feelings from coming to mind.   
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
 
 
7.  When I am startled, I notice what is going on inside my body.   
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
 
 
8.  I wish I could control my emotions more easily.   
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
 
 
9.  When I walk outside, I am aware of smells or how the air feels against my face.   
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
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10.  I tell myself that I shouldn’t have certain thoughts.   
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
 
 
11.  When someone asks how I am feeling, I can identify my emotions easily.  
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
 
 
12.  There are things I try not to think about.   
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
 
 
13.  I am aware of thoughts I’m having when my mood changes.   
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
 
 
14.  I tell myself that I shouldn’t feel sad.   
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
 
 
15.  I notice changes inside my body, like my heart beating faster or my muscles getting tense.   
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
 
 
16.  If there is something I don’t want to think about, I’ll try many things to get it out of my mind.   
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
 
 
17.  Whenever my emotions change, I am conscious of them immediately.   
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
 
 
18.  I try to put my problems out of mind.   
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
 
 
19.  When talking with other people, I am aware of the emotions I am experiencing.   
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
 
 
20.  When I have a bad memory, I try to distract myself to make it go away.   
  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes  Often    Very Often 
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Appendix D 
Experiences Questionnaire 
We are interested in your recent experiences. Below is a list of things that people sometimes 
experience. Next to each item are five choices: “never”, “rarely”, “sometimes”, “often”, and “all the 
time”. Please select one of these to indicate how much you currently have experiences similar to those 
described. Please do not spend too long on each item – it is your first response that we are interested 
in. Please be sure to answer every item. 
  
1.  I am better able to accept myself as I am. 
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes            Often                       All the  
         time 
 
2.  I can slow my thinking at times of stress. 
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes            Often                       All the  
         time 
 
3.  I notice that I don't take difficulties so personally.    
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes            Often                       All the  
         time 
 
4.  I can separate myself from my thoughts and feelings.   
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes            Often                       All the  
         time 
 
5.  I can take time to respond to difficulties. 
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes            Often                       All the  
         time 
 
6.  I can treat myself kindly.   
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes            Often                       All the  
         time 
 
7.  I can observe unpleasant feelings without being drawn into them. 
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes            Often                       All the  
         time 
 
8.  I have the sense that I am fully aware of what is going on around me and inside me. 
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes            Often                       All the  
         time 
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9.  I can actually see that I am not my thoughts.   
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes            Often                       All the  
         time 
 
10.  I am consciously aware of a sense of my body as a whole.   
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes            Often                       All the  
         time 
 
11.  I can view things from a wider perspective.  
○   ○   ○   ○   ○ 
Never   Rarely   Sometimes            Often                       All the  
         time 
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Appendix E 
Satisfaction with Life Scale 
 
Below are five statements with which you may agree or disagree. Please indicate your agreement with 
each item by selecting the most appropriate response. Please be open and honest in your responding.    
 
1. In most ways my life is close to my ideal.   
 
○ Strongly Disagree  
○ Disagree  
○ Slightly Disagree  
○ Neither Agree or Disagree  
○ Slightly Agree  
○ Agree  
○ Strongly Agree     
 
2. The conditions of my life are excellent.   
 
○ Strongly Disagree  
○ Disagree  
○ Slightly Disagree  
○ Neither Agree or Disagree  
○ Slightly Agree  
○ Agree  
○ Strongly Agree     
 
3. I am satisfied with life.   
 
○ Strongly Disagree  
○ Disagree  
○ Slightly Disagree  
○ Neither Agree or Disagree  
○ Slightly Agree  
○ Agree  
○ Strongly Agree     
 
4. So far I have gotten the important things I want in life.   
 
○ Strongly Disagree  
○ Disagree  
○ Slightly Disagree  
○ Neither Agree or Disagree  
○ Slightly Agree  
○ Agree  
○ Strongly Agree     
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5. If I could live my life over, I would change almost nothing. 
 
○ Strongly Disagree  
○ Disagree  
○ Slightly Disagree  
○ Neither Agree or Disagree  
○ Slightly Agree  
○ Agree  
○ Strongly Agree   
  
83 
 
  
 
Appendix F 
Positive and Negative Affect Scale 
 
This scale consists of a number of words that describe different feelings and emotions. Read each item 
and then list the number from the scale below next to each word.  Indicate the extent you have felt this 
way over the past week. 
 
1. Interested  
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
 
 
2. Distressed 
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
 
 
3. Excited   
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
 
 
4. Upset 
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
 
 
5. Strong   
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
 
 
 
6. Guilty 
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
 
 
7. Scared 
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
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8. Hostile 
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
 
 
9. Enthusiastic 
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
 
 
10. Proud   
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
 
 
11. Irritable 
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
 
 
12. Alert 
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
 
 
13. Ashamed 
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
 
 
14. Inspired 
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
 
 
15. Nervous 
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
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16. Determined 
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
 
17. Attentive 
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
 
 
18. Jittery 
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
 
 
19. Active 
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
 
 
20. Afraid 
 
○   ○   ○   ○   ○ 
Very slightly         A Little       Moderately          Quite a     Extremely 
or Not at all                bit 
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Appendix G 
Revised Fibromyalgia Impact Questionnaire 
 
For each of the following 9 questions check the box that best indicates how much your fibromyalgia 
made it difficult to perform each of the following activities during the past 7 days. If you did not 
perform a particular activity in the last 7 days, rate the difficulty for the last time you performed the 
activity. If you can’t perform an activity, check the last box. 
 
Brush or comb your hair 
          
No difficulty □      □      □      □      □      □      □      □      □      □      □ Very difficult 
 
Walk continuously for 20 minutes 
          
No difficulty □      □      □      □      □      □      □      □      □      □      □ Very difficult 
 
Prepare a homemade meal 
          
No difficulty □      □      □      □      □      □      □      □      □      □      □ Very difficult 
 
Vacuum, scrub or sweep floors 
          
No difficulty □      □      □      □      □      □      □      □      □      □      □ Very difficult 
 
Lift and carry a bag full of groceries 
          
No difficulty □      □      □      □      □      □      □      □      □      □      □ Very difficult 
 
Climb one flight of stairs 
          
No difficulty □      □      □      □      □      □      □      □      □      □      □ Very difficult 
 
Change bed sheets  
          
No difficulty □      □      □      □      □      □      □      □      □      □      □ Very difficult 
 
Sit in a chair for 45 minutes 
          
No difficulty □      □      □      □      □      □      □      □      □      □      □ Very difficult 
 
Go shopping for groceries 
          
No difficulty □      □      □      □      □      □      □      □      □      □      □ Very difficult 
  
 
 
For each of the following 2 questions, check the box that best describes the overall impact of your 
fibromyalgia over the last 7 days: 
 
Fibromyalgia prevented me from accomplishing goals for the week  
 
Never □      □      □      □      □      □      □      □      □      □      □ Always 
 
I was completely overwhelmed by my fibromyalgia symptoms  
 
Never □      □      □      □      □      □      □      □      □      □      □ Always 
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For each of the following 10 questions, select the box that best indicates your intensity of these 
common fibromyalgia symptoms over the past 7 days: 
 
Please rate your level of pain  
 
No pain  □      □      □      □      □      □      □      □      □      □      □ Unbearable pain 
 
Please rate your level of energy 
 
Lots of energy  □      □      □      □      □      □      □      □      □      □      □ No energy  
 
Please rate your level of stiffness  
 
No stiffness  □      □      □      □      □      □      □      □      □      □      □ Severe stiffness 
 
Please rate the quality of your sleep 
 
Awoke well  □      □      □      □      □      □      □      □      □      □      □ Awoke very 
tired rested               
 
Please rate your level of depression  
 
No depression □      □      □      □      □      □      □      □      □      □      □ Very depressed  
 
Please rate your level of memory problems  
 
Good memory □      □      □      □      □      □      □      □      □      □      □ Very poor  
       memory 
Please rate your level of anxiety 
 
Not anxious  □      □      □      □      □      □      □      □      □      □      □ Very anxious 
 
Please rate your level of tenderness to touch 
 
No tenderness  □      □      □      □      □      □      □      □      □      □      □ Very tender 
 
Please rate your level of balance problems  
 
No imbalance  □      □      □      □      □      □      □      □      □      □      □ Severe 
imbalance  
 
Please rate your level of sensitivity to loud noises, bright lights, odours and cold  
 
No sensitivity  □      □      □      □      □      □      □      □      □      □      □ Extreme  
       sensitivity 
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Appendix H 
Overview of the Ethic Approval Process 
 
The first stage in developing this study was to submit a research proposal which outlined a 
brief review of the relevant literature, the main research question and hypotheses, as well as the 
planned study methodology and analysis to the Division of Clinical Psychology Research Committee 
for peer review. A response was received on 13th November 2012 advising some minor amendments 
to the proposal. The reviewer comments were discussed with the research supervisors, and the 
proposal was revised accordingly. A response was sent to the committee on 3rd January 2013 which 
specified how the comments had been addressed, along with a revised copy of the research proposal. 
A letter confirming that the Division of Clinical Psychology Research Committee formally approved 
the proposal was received on 27th February 2013. 
The second stage, which ran somewhat in parallel to the first and third stage, was to seek 
support from FM charities to advertise the study. Fibromyalgia UK and Fibroaction were identified as 
national UK charities with large online communities. As such, enquiries were made as to whether they 
would consider advertising the study to their members. Both charities provisionally agreed to 
advertise the study via their websites and social media pages, pending ethical approval. 
The third stage of creating the current study was to apply for ethical approval. The study 
aimed to recruit a community sample of individuals living with FM, as opposed to recruiting from 
NHS services. The reason behind this decision was that it was hypothesised that it would be possible 
to target a more heterogeneous sample, from people who were living well with FM to those who had 
more difficulties because of it. In this sense, the study sample represented a non-clinical sample and 
ethical approval was sought from the Institute of Psychology, Health and Society (IPHS) Research 
Ethics Committee. The following documents were submitted to IPHS Research Committee: 
 Application form for approval of a project involving human participants, human data, or human 
material 
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 Participant information sheet 
 Consent form 
 Debriefing page 
 Study adverts 
 Study measures 
 Research proposal 
 
The IPHS granted the project ethical approval on 8th May 2013 via expedited review. 
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Appendix I  
Participant Information sheet. 
 
Title of Study 
 
Well-Being in Fibromyalgia. 
 
 
Thank you for taking the time to read this information sheet. 
 
You are being invited to take part in an online questionnaire study. Before you decide 
whether to you wish to take part in the study or not, please read the following information 
carefully. The following information will explain why the research is being done, what you 
will be asked to do, and about confidentiality. Please take time to read the following 
information carefully and feel free to ask us if you would like more information or if there is 
anything that you do not understand. If you would like anymore information or have any 
questions please contact me or my supervisor using the contact details below. Please also feel 
free to discuss this with your friends, relatives or GP if you wish.  
 
To take part you must be 18 years or older, and a resident of the United Kingdom. 
 
As a thank you for completing the questionnaire, you will be given the opportunity to enter a 
prize draw where you can win either 1 x 50 or 10 x £10 high street store vouchers. 
 
What is the purpose of the study? 
 
The purpose of the study is to explore which psychological factors may contribute to well-
being in people with Fibromyalgia. There has been lots of research that shows that people 
with physical health conditions (such as Fibromyalgia) who maintain higher levels of well-
being do well, for example they live longer, and need to have less healthcare appointments 
 
Why have I been chosen to take part? 
 
As we are interested in learning more about how to improve well-being in individuals with 
Fibromyalgia, we are specifically looking for individuals with a diagnosis of the condition. 
Furthermore, we are only inviting individuals who are over the age of 16 and residents of the 
United Kingdom to take part for ethical reasons to do with gaining appropriate consent to 
take part. 
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Do I have to take part? 
 
No, taking part is voluntary.  If you don’t want to take part, you do not have to give a 
reason and no pressure will be put on you to try and change your mind.  You can stop the 
questionnaire at any time. Incomplete questionnaires will be permanently deleted from the 
data set.  
 
 
What will happen if I take part? 
 
If you agree to take part, you will first be asked to check that this study is right for you, and 
that you are happy to take part.  
You will then be asked to complete a set of online questionnaires.  
 
We estimate that the questionnaire shall take no longer than 20 minutes to complete in a 
single, non-stop sitting. However, if you would feel more comfortable taking breaks, it is 
okay to leave the questionnaire from time to time, before returning to carry on. If you would 
like to do this, it is important to leave you computer switched on, and the questionnaire up on 
the screen. If you were to close the internet browser, or log off the computer then your 
answers so far would be lost. 
All questions will be presented in English; unfortunately no other language options are 
available. As such you may want to consider if this will cause difficulties for you in anyway 
before agreeing to take part. You can do this in any location you choose. Though none of the 
questions are of a very personal nature, you may still wish to pick somewhere with 
reasonable privacy. 
 
Once you have completed the questionnaire, you will have finished the study. There will be 
no further questionnaires or any other kind of follow up in the future. 
 
 
Expenses and / or payments 
 
At the end of the study, you will be offered the opportunity to enter a prize draw to win prizes 
of High Street Vouchers. The prizes available are: 1 x First Prize of £50 high street vouchers, 
10 x Runner up Prizes of £10 high street vouchers. If you wish to be entered into the draw, 
you will be asked to provide your email address. Once the study closes, the draw will take 
place and you will be informed by email whether or not you have won a prize. You’re email 
address will be stored in a separate place to your questionnaire answers to ensure you 
anonymity. 
 
 
Are there any risks in taking part? 
 
There are no anticipated risks to taking part. If any of the questions raise concerns you are 
advised to contact your GP for support, and/or discuss them with someone you trust.  
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You can also gain support by contacting an independent support organisation such as The 
Samaritans: 08457 90 90 90 or www.samaritans.org 
 
 
Are there any benefits in taking part? 
 
There are no immediate benefits to participating in the research, besides the chance to win 
high street vouchers should you wish to enter the prize draw at the end.  
 
 
What if I am unhappy or if there is a problem? 
 
Please contact Kathryn Bourne (kbourne@liverpool.ac.uk) who will try to help. If you remain 
unhappy or have a complaint which you feel you cannot come to us with then you should 
contact the Research Governance Officer on 0151 794 8290 (ethics@liv.ac.uk). When 
contacting the Research Governance Officer, please provide details of the name or 
description of the study (so that it can be identified), the researcher(s) involved, and the 
details of the complaint you wish to make. 
 
Will my participation be kept confidential? 
 
If you choose to take part in the study, any information you give will be anonymised i.e. no 
one will know your identity. Your responses will only be viewed by the researchers involved 
in the study. If you choose to take part in the study and then decide it is not for you, you will 
be able to withdraw at any time during the online questionnaire. You can do this by closing 
the internet browser. Incomplete data sets will be deleted from the study data. However, once 
you have fully completed the study, it will unfortunately not be possible to withdraw your 
data as there will be no way of identifying which set of answers is your own. 
 
 
What will happen to the results of the study? 
 
The results of the study will be written up as part of a Doctoral Degree in Clinical 
Psychology. The study may also be published in an academic journal. A summary of the 
anonymised results will be posted on the Fibromyalgia UK and Fibroaction websites. 
 
What will happen if I want to stop taking part? 
 
You have the right to stop answering the questionnaire at any point, without needing to give 
any explanation. Should you wish to do this, simply close the internet browsing window you 
are doing the questionnaire on. Any questionnaires that are not answered until the end will be 
withdrawn from the study and permanently deleted. Unfortunately, once you have completed 
the study it will not be possible to ask for your data to be removed, as we will have no way of 
identifying which sets or answers are your own. 
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Who can I contact if I have further questions? 
 
Kathryn Bourne 
Trainee Clinical Psychologist 
Doctorate of Clinical Psychology Programme 
University of Liverpool 
Email:  kbourne@liverpool.ac.uk 
 
This study is supervised by  Dr Jen Unwin at Southport & Ormskirk Hospital Trust and Dr 
Joanne Dickson at the University of Liverpool. 
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Appendix J 
Consent Form 
 
 
 
 
 
 
 
 
 
 
 
The contact details of lead Researcher are: 
 
Kathryn Bourne 
Trainee Clinical Psychologist 
Doctorate of Clinical Psychology Programme 
University of Liverpool 
Email:  kbourne@liverpool.ac.uk 
 
 
Title of Research 
Project: 
 
Well-Being in Fibromyalgia 
 
 
 
Please 
check 
box 
Researcher(s) Kathryn Bourne 
Dr Joanne Dickson (Chief Investigator) 
Dr Jen Unwin 
 
1. I confirm that I am 18 years of age or older. 
   
 
 
2. I confirm that I am a resident of the United Kingdom. 
 
 
 
3. I confirm that I have read and have understood the information sheet 
dated [DATE] for the above study. I have had the opportunity to 
consider the information, ask questions and have had these answered 
satisfactorily. 
 
 
 
 
4. I understand that my participation is voluntary and that I am free to 
stop taking part at any time without giving any reason, without my 
rights being affected.   
 
5. I agree to take part in the above study.    
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Mediator
DVIV
Appendix K 
Structural Equation Modelling (SEM) 
 
SEM is largely a confirmatory, as opposed to exploratory, approach that involves the testing 
of a hypothesised structural model of how variables of interest relate to each other. Put simply, SEM 
works by estimating an implied “perfect” covariance matrix and parameters based on the hypothesised 
structural model. It then compares the actual observed data to the implied model to see how well it 
fits. Most SEM programmes produce a number of goodness of fit indices that can be used to infer how 
well the model fits the data (Byrne, 2010). The most common of which are discussed below. 
The advantages of using an SEM approach in this study is that it allowed for the conducting 
of simultaneous equations that looked at multiple relationships amongst multiple variables at the same 
time. For example in SEM it is possible to estimate: the direct effect (c)  an IV has on a given DV, the 
indirect effect (ab) an IV may have on a given DV through a hypothesised mediating variable, and 
also the total effect (c + ab) that the IV has on the given DV, all in one step. The example given is a 
simple mediation analysis for clarity of explanation. SEM’s true strength, however, is that it allows 
for the testing of much more complicated models that may have multiple IVs, mediating variables and 
DVs. 
 
 
            
            
            
            
            
            
            
            
            
    
 
 
 
a b 
c 
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SEM can be performed using a number of possible estimation methods, the most common of 
which is the Maximum Likelihood Method (ML).  The ML approach makes the assumptions that (i) 
the data sample is large, (ii) the variables are normally distributed, and (iii) the distribution of the 
observed variables has multivariate normality (Byrne, 2010). 
When estimating the model, AMOS will provide several Goodness of Fit Indices (GFI). 
Although there is no absolute rules about which GFIs to report, the generally agreed consensus is to 
report the chi-square value (χ2), the comparative fit index (CFI), the root mean square error of 
approximation (RMSEA) and the standardised root mean square residual (RMSR) (Hu and Bentler, 
1999). 
The χ2 tests the null hypothesis that the proposed model is no different from the actual data. 
As such, a non-significant result indicates a well-fitting model. However, the χ2 is very sensitive to 
sample size so that in large sample sizes the χ2 is very likely to be significant (Byrne, 2010).  
The RMSEA is a ‘parsimony’ index measure that penalises models that estimate many 
parameters, but rewards bold models with more constraints. It normally favours the model with fewer 
parameters, unless additional parameters make a considerable improvement to model fit. It compares 
the fit of a saturated model (in which it is assumed that everything is related) to the hypothesised 
model, whilst adjusting for complexity using the error per degree of freedom. A score of ≤ .06 
indicates good fit (Hu & Bentler, 199), with scores over 1.00 indicating a poor fit (Byrne, 2010). 
The CFI is an incremental analysis of fit that compares the χ2 of the tested model to the χ2 null 
model, whilst accounting for sample size. CFI values range from 0 to 1, with values ≥ .95 indicating a 
good fit (Hu & Bentler, 1999).  
The SRMR is a measure of fit based on the difference between residuals in the observed 
model and the hypothesised model. Values range from 0 to 1, with values ≤.08 indicating a good fit 
(Hu & Bentler, 1999). 
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Appendix L 
Data Preparation 
 
The online questionnaire was a forced-choice design, which meant that participants had to 
respond to all study items on a page in order to continue to the next page and complete the study. It 
was made clear to participants that if they did not want to answer any questions they could opt out of 
the study by closing their browser window and that any incomplete data sets would be treated as 
withdrawals and removed from the final sample. The study link was accessed approximately 2,440 
times and 1,169 people started the study. Of those who started the study, 186 did not complete all the 
questions, 23 were identified as duplicates and 24 reported that they did not have a diagnosis of FM. 
As such, for the 936 participants included in the analysis there was no missing data. 
Subscale and or total scores were computed in SPSS as per the instructions of each measure. 
The next step was to asses for skewness and kurtosis within each of the key study variables. As the 
data set was very large, this was likely to bias traditional tests of normality within SPSS, such as the 
Shapiro-Wilk test, as well as methods of assessing normality via calculating the z-scores for the 
skewness and kurtosis values (Field, 2013). Therefore, it was decided that the most meaningful 
method of assessing normality was to look at the distribution of data for each variable using 
histograms. This process revealed that SWLS, PA and Hope scores were all somewhat positive 
skewed. A log transformation was applied and a subsequent review of the histograms of the 
transformed variables revealed them to be acceptable.  
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Appendix M 
Comparing descriptive statistics with normative data 
 
The sample means for each variable in the current study were compared to previously 
reported normative data. All of the comparative samples consisted of non-clinical participants, with 
the exception of the measure of decentering (EQ, Fresco et al., 2007), which reported a mixed sample 
of non-clinical participants and participants in remission from Major Depressive Disorder. 
Independent t-tests were used to see whether the norms of the current sample were statistically 
different to those reported previously. The descriptive data and t-test statistics are reported in the table 
overleaf. Participants in the current sample reported significant lower levels of SWL, PA, hope, 
mindful acceptance and decentering. The current sample also reported significantly higher levels of 
NA and FM-related difficulties. There was no statistical difference between mindful awareness in the 
current sample and that reported previously. 
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 Current Sample 
(n = 936) 
Comparative 
data 
 
Variable Mean SD Mean SD t p 
SWLa  14.66 7.05 23.50 6.43 15.47 <.001 
PAb 23.35  8.45 31.31 7.65 21.77 <.001 
NAb 26.31 9.35 16.00 5.90 29.24 <.001 
Hopec 23.43 10.68 37.15 6.33 25.06 <.001 
M’ful Awared 36.48 5.94 36.65 4.93 0.60 n.s. 
M’ful Acceptd 25.31 6.60 30.49 5.84 15.32 <.001 
Decenteringe 3.00 0.63 3.28 0.91 5.77 <.001 
FIQRf 68.54 18.52 56.60 19.90 8.20 <.001 
Note. SWL = Satisfaction with Life Scale; PA = Positive Affect; NA = Negative Affect, M’ful Aware = 
Mindful Awareness; M’ful Accept = Mindful Acceptance; FIQR = Fibromyalgia Impact 
Questionnaire Revised. 
a comparative sample from Deiner et al. (1985), N = 176. 
b comparative sample from Crawford & Henry (2004), N = 1003. 
c comparative sample from Snyder et al. (1996), N = 444. 
d comparative sample from Cardaciotto et al. (2008), study 2, N = 559. 
e comparative sample from Fresco et al. (2007), sample 3, N = 270. 
f comparative sample from Bennett et al. (2009), N = 202. 
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Appendix N 
Covariance, Residual Covariance and Standardised Residual Covariance Matrices for the 
modified Model. 
 
Covariance Matrix 
 Aware Accept Hope Decenter FM NA PA SWL 
Aware 35.28        
Accept -9.16 43.53       
Hope 0.24 0.46 0.05      
Decentre 17.52 11.82 0.93 48.36     
FM -4.66 -46.56 -2.34 -46.69 342.78    
NA -5.99 -23.40 -1.25 -31.62 92.45 87.40   
PA 0.10 0.40 0.02 0.54 -1.56 -0.59 0.03  
SLW 0.12 0.46 0.03 0.63 -1.83 -0.95 0.02 0.05 
 
Unstandardised Residual Matrix 
 Aware Accept Hope Decenter FM NA PA SWL 
Aware         
Accept 0.00        
Hope 0.00 0.00       
Decenter 0.00 0.00 0.00      
FM -2.02 2.97 -0.01 0.00     
NA 5.21 -9.19 0.15 0.89 3.29    
PA .11 -0.14 0.00 0.05 0.08 0.00   
SWLS -.08 -0.04 0.00 -0.10 -0.15 0.01 0.00  
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Standardised Residual Matrix 
 Aware Accept Hope Decenter FIQR NA PA SWL 
Aware         
Accept 0.00        
Hope 0.00 0.00       
Decenter 0.00 0.00 0.00      
FM -0.56 0.69 -0.07 0.00     
NA 2.85 -4.26 1.86 0.38 0.51    
PA 3.45 -3.62 1.50 1.26 0.75 0.00   
SWL -1.93 -0.78 0.97 -1.93 -1.02 0.14 -0.30  
Note. Aware = mindful awareness; Accept = mindful acceptance; Decenter = Decentering; FM = 
fibromyalgia-related difficulties: NA = negative affect: PA = positive affect; SWL = satisfaction with 
life. 
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Appendix O 
PAIN: Author Guidelines 
 
 
Comprehensive Reviews  
Comprehensive reviews offer an extensive summary of an important topic, field, discovery, or 
innovation. Narrative, comprehensive reviews are encouraged where they offer insight across 
traditional domains, focus on methods and measurement, or introduce conceptual or philosophical 
direction. Such reviews are discouraged for evidence synthesis or for the summary of research results 
where meta-analyses are possible. Comprehensive reviews should be well-illustrated with high-
quality figures. There is no specific word limit, but reviews longer than 6,000–8,000 words are 
discouraged. The manuscript must contain an Abstract (unstructured, 250 words) Introduction, 
Methods, Results, Discussion, Acknowledgments, and References.  
 
Clinical/Basic Science Research Reports  
The manuscript must contain an Abstract (unstructured, 250 words), Introduction (500 
words), Methods (no word limit), Results (no word limit), Discussion (1,500 words), 
Acknowledgments, and References.  
 
General Guidelines 
File format should be Microsoft Word, and manuscript pages should be numbered.  The title 
page should include the following: (i) complete title (preferably no chemical formulas or arbitrary 
abbreviations); (ii) full names of all authors; (iii) complete affiliations of all authors; (iv) the number 
of text pages of the entire manuscript (including pages containing figures and tables) and the actual 
number of figures and tables; (v) the author to whom correspondence should be sent and this author's 
complete mailing address, telephone number, fax number, and e-mail address, and, if available, 
institutional URL.  
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Acknowledgments. Place acknowledgments at the end of the text before the reference list and 
specify the following: (1) contributions that need acknowledging but do not justify authorship; (2) 
acknowledgments of technical help; (3) acknowledgments of financial and material support, 
specifying the nature of the support; (4) financial arrangements that may represent a possible conflict 
of interest. Conflict of Interest. A Conflict of Interest statement must be included for all manuscripts 
within the Acknowledgments section. Even if there are no conflicts of interest, please explicitly state 
this. 
 
Referencing 
 Cite literature references in the text using bracketed numbers that correspond to the alphabetized 
and numbered reference list as follows: "Pain is made worse if you hit the already injured site 
[15]." For multiple references in the text, please use the format [number,number] (with a comma 
and no spaces). For example: [2,4,28,33].  
 All references cited in the text must be listed at the end of the paper. They should be numbered, 
double spaced, and arranged alphabetically by first author last name.   
 All authors must be listed in the references; the use of et al. is not acceptable.  
 References must be complete, including initial(s) of author(s) cited, title of paper, journal, year of 
publication, and volume and page numbers.  
 For citations of books, the following uniform sequence should be maintained: author(s), title of 
article, editor(s), complete title of book, place of publication, publisher, year, and page numbers.  
 Journal titles should be abbreviated according to the National Library of Medicine’s Index 
Medicus. Please refer to the NLM website’s FAQ on how to find Index Medicus journals: 
www.nlm.nih.gov/services/aim.html.  
 Unpublished data, personal communications, abstracts that cannot be retrieved by casual readers 
(e.g., meeting abstracts that require logging into a members-only site), and other inaccessible 
materials should not be listed as references. Unpublished materials may be cited in parentheses 
within the text.  
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 For manuscripts containing citations that are in press, authors must have electronic copies 
immediately available in case reviewers/editors request these materials.  
 URLs should be included for all references that are publicly accessible via the Internet.  
 
Examples:   
 [1] Adams CWM. Neurohistochemistry. Amsterdam: Elsevier, 1965.  
[2] Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception 
and regulation in health and disease. Eur J Pain 2005;9:463-84.   
[3] Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 
2005;5:718-25.  
 [4] Turner JA. Coping and chronic pain. In: Bond MR, Charlton JE, Woolf CJ, editors. Pain research 
and clinical management. Proc. VIth World Congress on Pain, Vol. 4. Amsterdam: Elsevier,; 1991. 
pp. 219-227. 
 
Figure legends  
Provide each illustration with a title and an explanatory legend. The title should be part of the 
legend; do not reproduce the title and legend on the figure itself. Legends should appear on a separate 
page at the end of the manuscript. Each legend should be numbered consecutively with Arabic 
numerals (i.e., Fig. 1, Fig. 2, etc.), and should begin with the number of the illustration to which they 
refer. Explain all symbols and abbreviations used in the figure.  
 
Tables  
Tables, with their captions and legends, should be intelligible with minimal reference to the 
text. Tables of numerical data should each be typed (double spaced) on a separate page, numbered in 
sequence with Arabic numerals (i.e., Table 1, Table 2, etc.), provided with a title/heading, and 
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referred to in the text as Table 1, Table 2, etc. Provide a detailed description of its contents and any 
footnotes below the body of the table. 
 
 
